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ABSTRACT OF THE THESIS

EFFECTS OF PERIODIC ACCELERATION (pGz) ON NITRIC OXIDE DURING
RESUSCITATION IN ANESTHETIZED PIGS
by

Ingrid M. Gunnlaugsson

Florida International University, 2003
Miami, Florida

Professor John McDonough, Major Professor
The purpose of this study was to compare the response of Nitric Oxide (NO) during

periodic acceleration (pGz) to standard CPR in anesthetized pigs. PGz increases blood
flow during resuscitation and research suggests NO may be the mediator. Twelve
anesthetized pigs (9.5 to 12 kg) were stimulated into ventricular fibrillation and

resuscitated via either pGz or standard CPR. Serum NO levels were drawn prior to
ventricular fibrillation and at 10 and 20 minutes during resuscitation. Mean NO levels
were measured using three methods: an NO Meter (ISO-NO Mark II), using both a

reductase and deproteinization method, and a Greiss Reaction Assay. Data were analyzed
using Friedman matched samples and Kruskal-Wallis signed ranks test. While significant

differences were noted in some of the measurements, these differences were inconsistent.
Variations in the NO levels in this study indicate problems with both the sampling

modality and the reduction methods utilized in measurement.
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1. Introduction

Overview

Cardiac arrest, cardiopulmonary resuscitation (CPR), and low blood flow states
seriously alter many physiological responses. CPR related circulatory impedance and

pulmonary hypoxia result in biological alterations including: hyperkalemia,
hypocalcemia, abnormal arterial blood gases, and increased nitric oxide (NO) levels

(Bellamy et al., 1996; Schleien, Kuluz, & Gelman, 1998). Research studies indicate that
increased serum potassium, along with decreased ionized calcium, occur during lengthy
CPR events and possibly cause countershock arrhythmias and the failure of resuscitation
efforts (Niemann & Cairns, 1999). Research studies also suggest that CPR induced

increases in endogenous NO levels result in cerebral and cardiovascular hyperemia and
injury further impeding the success of resuscitative procedures (Schleien et al, 1998). In
contrast, additional evidence exists postulating that the vasodilatory properties of
increased NO levels may actually be beneficial in decreasing neuronal and cardiovascular
destruction and therefore possibly increase resuscitation survival rates (Adams, Mangino,

Bassuk, Kurlansky, & Sackner, 2001a; Mossad, 2001; Schleien et al., 1998). Further

research implies that NO may play a role in consciousness, sedation, and analgesia

(Matsouka, Watanabe, Isshiki, & Quock, 1997; Tonner, Scholz, Schlamp, & Schulte,
1997).

Standard CPR, which originated in 1965, has been the focus of numerous animal and
human studies (Schwenzer, Smith, & Durbin, 1993). As swine have similar metabolic
and cardiovascular functions to humans, with a similar coronary anatomy, they are

frequently used in modern CPR research (Idris et al., 1996). Standard CPR, as defined by
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the Utstein-Style Guidelines for Uniform Reporting of Laboratory CPR Research, is

described as “external closed chest compression and ventilation” (Idris et al., 1996, p.
529). Successful standard CPR depends on the ability of the chest compressions, to

provide adequate blood flow, and the ability of ventilation mechanisms to provide and
maintain sufficient oxygenation. Insufficient circulation, and resulting ischemia, can set
off a cascade of hemodynamic abnormalities (Pinchak, Hancock, Hagen, & Hall, 1998).

As the goal of CPR is to provide and maintain adequate circulation and oxygenation,
as well as increase patient survival rates, continued research is needed to facilitate and
implement successful resuscitation methods (Jawan et al., 2000). In an ongoing study at

the Harry Pearlman Research Institute at Mount Sinai in Miami Beach, Florida,

intraoperative resuscitation on anesthetized pigs, using a periodic acceleration (pGz)
approach, is under investigation. Resuscitation via pGz motion is implemented by

moving the anesthetized animal in a foot to head direction known as a "z-plane” using a
platform device (Adams, Mangino, Bassuk, Inman, & Sackner, 2000b). By manipulating
the platform’s speed and frequency, acceleration forces ventilate the anesthetized and

arrested pig’s lungs and stimulate cardiovascular function (Adams et al., 2000; 2001a).
The pGz platform’s movement also causes hemodynamic vessel shear stress that may
increase the production of endogenous NO (Adams et al., 2000; 2001a). There is a

possibility that pGz resuscitation may be applicable to humans as an alternate to standard
CPR. To date, little research exists on pGz or possible related physiological responses

such as increases in NO (Adams et al., 2000b; Adams et al., 2001a; Jawan et al., 2000).
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Study Purpose
The purpose of this study was to compare the physiological responses during pGz
resuscitation to standard cardiopulmonary resuscitation in anesthetized and arrested pigs.

Statement of the Research Problem

Endogenous NO has been implicated as a modulator of various physiological
responses including: regulation of blood pressure and blood flow, stimulation of vascular

relaxation, transmission of molecular signals, inhibition of platelet aggregation, and
activation of cytokine induced inflammatory neutrophil and macrophage migration,
nociception and the maintenance of consciousness (Kelly, Balligand, & Smith, 1996;

Fukuda et al., 1999). Standard CPR has commonly depended on the use of vasopressors,
such as epinephrine and vasopressin, in shunting circulation to the brain and
cardiovascular areas in order to maintain the oxygenation of those tissues (Krismer et al.,

2000). Coronary perfusion pressure has primarily been the deciding factor as to success

in restarting an arrested heart (Achleitner et al., 2000). Nitric oxide, on the other hand, is
a potent vasodilator and this vasodilatory response has long been viewed as detrimental

to resuscitation efforts (Schleien, 1998). Nitric oxide is believed to be stimulated by
receptor dependent and independent agonists, hypoxic events, and hemodynamic shear
stresses (Busse, Mulsch, Fleming, & Hecker, 1993; Vanhoutte, 1999). Cardiac arrest

situations cause circulatory and pulmonary impedance resulting in ischemia and hypoxia.
Movement of the pGz platform device produces vasoactive modulators such as vascular
shear stress and pulsatile vessel stretch (Adams et al., 2001a; Bellamy et al., 1996). Thus

an increase in NO release is expected with pGz movement resuscitation. Whether or not
an increase in endogenous NO actually occurs with pGz and whether such an increase is
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beneficial, is not known. Therefore, the study addressed the following problem: To what
extent does pGz motion affect the physiological response of nitric oxide during

intraoperative resuscitation in anesthetized pigs?
Specific Aims
1. To determine the effects of intraoperative pGz on NO levels in anesthetized pigs.

2. To compare the differences in NO levels during pGz to standard CPR in

anesthetized pigs.
Hypothesis

In order to achieve these aims, the following is hypothesized in arrested and

anesthetized pigs:
H\. There is a difference between NO levels during pGz resuscitation and baseline
levels prior to pGz resuscitation.

Hi. There is a difference between NO levels during standard CPR and baseline levels

prior to standard CPR.
Hi. The NO levels are greater during pGz resuscitation than during standard CPR.

Variables
The variables in this study are as follows:
1. Dependent variable: Nitric oxide (NO) levels.

2. Independent variables: intraoperative resuscitation (pGz and standard CPR).
Definition of Key Terms

Intraoperative resuscitation
Intraoperative resuscitation refers to the cardiovascular and pulmonary resuscitation of
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anesthetized pigs, that have had induced ventricular fibrillation and subsequent cardiac
arrest, via pGz or standard CPR.

pGz
The pGz motion platform is a device that moves the animal in a foot to head
direction, while varying the speed and frequency of the acceleration motion, with the

purpose of ventilating and stimulating cardiovascular function in arrested pigs.
Standard CPR

Standard CPR refers to external closed chest compressions and ventilation. Standard

chest compressions refer to “external chest compressions applied to the area of the chest
approximately the size of the heel of an adult’s hand” (Idris et al., 1996, p. 529).
Ventilation refers to “any movement of gas in and out of the lungs” (Idris et al., 1996, p.
529).
Nitric oxide
Nitric oxide (NO) is a colorless, odorless free radical gas and molecular intracellular

messenger that diffuses easily across the cell membrane and is thought to stimulate a
variety of physiological responses. Some of the physiological responses to NO include:
blood pressure regulation, vascular relaxation, platelet inhibition, behavioral modification

such as wakefulness and sedation, pain nociception and antinociception, and molecular
signal transmission (Fukada et al., 1999; Furchgott, 1999; Kelly et al., 1996). NO is
believed to be stimulated by receptor agonists, hypoxia, and hemodynamic shear stress

(Furchgott, 1999).

5

Assumptions
1. Cardiac arrest and standard CPR, with subsequent low blood flow states and

hypoxia, result in physiological alterations that include arterial blood gas
abnormalities, increased potassium, decreased ionized calcium, and increased
nitric oxide levels.

2. Successful standard CPR depends on the ability of chest wall compressions to
provide sufficient blood flow and the ability of ventilation methods to provide and

maintain sufficient oxygenation. Decompression of the chest wall, as occurs

during standard CPR, may negatively alter the lung volume capacity and
mechanical ventilation, with frequent high pressures, may injure lung parenchyma

(Adams et al., 2000b; Pinchak et al., 1998; Voelckel, et al, 2001).

3. Receptor dependent and independent agonists, hypoxia, and hemodynamic shear
stresses stimulate the production of NO (Busse et al., 1993). The pGz platform
movements generate hemodynamic shear stress and pulsatile vessel stretch
(Adams et al., 2001a). Hypoxia can occur during, or after, cardiac arrest and
resuscitation.

Significance to Nursing
The results of this study are relevant to clinical nursing practice and may add to the

knowledge base of nursing education. As staff nurses are the first to respond to patients in

cardiac arrest, and the first to initiate CPR, nurses must continually expand their
knowledge relating to resuscitation practices. Acute care facilities mandate that staff

nurses attend basic life support courses, biannually, and nurses that work in specialty
areas must also attend advanced life support courses. Critical care nurses generally
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receive patients, who have arrested and been successfully resuscitated, in the critical care

units and therefore must have additional knowledge of cardiac arrest, subsequent
resuscitation, low blood flow states, and the expected hemodynamic abnormalities and
physiological responses. Standardized treatment modalities are in place for many of these

alterations (Burden & Saufl, 2001; Mancini & Kaye, 1999).
Cardiac arrest is a possible complication intraoperatively and may result from

inadequate oxygen, in the anesthesia content itself, or possibly from depressed respiratory

function due to the anesthesia’s action (Guyton & Hall, 2000). As such, the practice of

nurse anesthesia requires both competencies in cardiac arrest situations and resuscitation
methods, as well as, knowledge of innovations in CPR techniques. The novel and

simplistic application of pGz makes it an attractive method of cardiopulmonary support
or adjunct to current CPR modalities. Resuscitation via pGz, and the subsequent
production of NO, may improve CPR outcomes in human populations. Therefore, study

findings will help determine if NO is increased during pGz, whether increased NO is
beneficial in cardiac resuscitation, whether pGz is a viable alternative to standard CPR in

decreasing mortality, and whether pGz has applicability in human populations.
The American Nurse Association’s (ANA) Code for Nurses may be applied to any
nursing area regarding professional standards and expectations of patient care during

cardiac arrest, CPR, intraoperative resuscitation, and subsequent abnormal physiological
responses (ANA, 1991). Unique and challenging situations arise involving the care of

patients intraoperatively, while undergoing anesthesia and surgery, and involving the
acutely ill patients in today’s critical care units (Burden & Saulf, 2001). As always,

nurses must maintain a competency based practice and must continue to acquire
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knowledge in relevant matters (ANA, 1991). Consequently, study results may help set the

stage for further research in areas such as the applicability and practicality of pGz in
human cardiac arrest situations.
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2. Literature Review
Introduction
Cardiac arrest is a global, ischemic assault that seriously stresses the physiological

responses of both human and animal populations. Ventricular fibrillation is the most

common, as well as, the most treatable cause of cardiac arrest; however, cardiac arrest
occurs in many other situations (American Heart Association, AHA, 1998).

Intraoperative administration of potent anesthetics, particularly succinylcholine, has been
implicated in arrest situations either as an anaphylactic or toxic response (Gronert, 2001;
Larach, Rosenberg, Gronert, & Allen, 1997; Wu, Rau, Lin, & Chan, 1997). Cardiac arrest

is also associated with other cardiac arrhythmias; trauma events, drowning, and can
accompany respiratory arrest in hypoxic situations (AHA, 1998). Cardiac resuscitation

efforts date back to the mid-1800s and research, to improve resuscitation methods,
continues in modern times (Woda, Dzwonczyk, Bernacki, Cannon, & Lynn, 1999).

Unfortunately, the majority of cardiac resuscitation efforts fail with overall survival rates

between 1 and 20% (Paiva, Kern, Hilwig, Scalabrini, & Ewy, 2000). Coronary perfusion
pressure, during prolonged CPR, is often less than adequate making the possibility of

retaining intact neurological function minimal (Eynon, 2000; Reid, Mullins, & Iyer,
1998). Successful resuscitation depends on maintenance of physiological factors such as:

serum potassium and calcium concentrations, acid-base pH, and possibly NO levels

(Niemann & Cairns, 1999; Ziglar, 2000).
Theoretical Framework

The focus of the study framework is the affect of cardiac arrest and pGz resuscitation

on physiological responses, particularly nitric oxide levels. The study framework
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concepts include: (1) cardiac arrest, (2) resuscitation, (3) circulation, (4) ventilation, (5)
vasoactive modulators, and (6) nitric oxide. Postulates suggested by the study framework
are that pGz produces hemodynamic shear stress and that this stress, along with hypoxia,

increases the production of NO. The conceptual model of the study framework (Figure

2.1) is based on evidence from the research studies cited in the literature review and the
study concepts are defined as follows:
(1) . Cardiac arrest refers to the “cessation of cardiac mechanical activity” (Idris et al.,

1996, p. 529). Cardiac arrest is induced in the study population via electrically produced
ventricular fibrillation.

(2) . Resuscitation refers to the use of standard CPR or pGz to restart the animals arrested

heart and stimulate circulation and ventilation. Standard CPR is defined as “external
chest compression and ventilation” (Idris et al., 1996, p. 529). The abbreviation pGz
refers to a device that moves an animal in a foot to head direction with the purpose of
stimulating circulation and ventilation (Adams et al., 2001a).

(3) . Circulation is defined as the movement of blood through the body as measured via
arterial pressures (Idris et al., 1996). Circulation is frequently less than adequate during

standard CPR (Eynon, 2000; Reid et al., 1998). Research indicates that pGz provides
excellent regional blood flow to the brain, heart, as well as abdominal organs (Adams,

Mangino, Bassuk, Kurlansky, & Sackner, 2001b).
(4) . Ventilation is defined as “any movement of gas in and out of the lungs” and includes

such movement as accompanies standard CPR and pGz (Idris et al., 1996, p. 529).
Ventilation during standard CPR frequently results in pulmonary impedance and hypoxia
(Adams et al., 2000b; Bellamy et al., 1996). Noninvasive negative pressure ventilation of
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anesthetized pigs has been supported during pGz in a manner similar to human
respiration and appears related to the thrust of the animal’s abdominal contents cephalic

toward the diaphragm (Adams, Mangino, Bassuk, & Sackner, 2000a).
(5) . Vasoactive modulators refer to such factors as hemodynamic shear stress, pulsatile

vessel stretch, and hypoxic events. Cardiac arrest and resuscitation cause circulatory and
pulmonary impedance and result in hypoxia and inadequate tissue perfusion and

oxygenation (Bellamy et al., 1996; Paiva et al., 2000; Reid et al., 1998). The movement

of pGz is thought to produce vascular hemodynamic shear stress and pulsatile vessel
stretch (Adams et al., 2001a).
(6) . Nitric oxide refers to a reactive diffusible free radical gas that is produced in the

vascular endothelium, and various other biological tissues, in response to such stimulants

as hypoxia, hemodynamic shear stress, pulsatile vessel stretch, and receptor agonists
(Busse et al., 1993; Miller et al., 1986).

The relationships postulated by the variables in the study framework are based on

previous research findings and linked via the following statements: Cardiac arrest and
resuscitation impede circulation and ventilation (Bellamy et al., 1996). Resuscitation, via

standard CPR and pGz, attempts to correct this impedance by increasing circulation and

ventilation with the goal of adequately oxygenating cardiac and cerebral tissue
(Schwenzer et al., 1993). Standard CPR is thought to produce various negative
physiological responses such as: hyperkalemia, hypocalcemia, and abnormal arterial

blood gases (Bellamy et al., 1996; Neimann & Cairns, 1998). Research has also indicated

that increased NO levels occur during standard CPR (Furchgott, 1999; Mossad, 2001;
Schleien et al., 1998). Additional research suggests that the production of NO is
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stimulated by hypoxic events, hemodynamic shear stress, and pulsatile vessel stretch
(Busse et al., 1993; De Keulenaer et al., 1998; Inoue et al., 1996; Miller et al., 1886;

Utematsu et al., 1995). The movement that occurs during pGz is thought to produce
hemodynamic shear stress, and pulsatile vessel stretch, and therefore stimulate the release

of NO (Adams et al., 2001a). Nitric oxide is a potent vasodilator and plays a role in
numerous physiological responses such as: blood pressure regulation, cerebral function,

skeletal muscle activity, and neuroendocrine mediation (Christopherson & Bredt, 1997;
Kelly et al., 1996). Whether or not an increase in NO production during pGz is beneficial

to resuscitation outcomes is, as yet, unknown.
Figure 2-1. Theoretical Framework.

12

Related Literature

Standard CPR
Early CPR consisted of a chest-pressure arm lift technique without accompanying

ventilation (Woda et al., 1999). Modern or standard CPR, composed of closed external
chest compressions and ventilation, originated in 1965 (Schwenzer et al., 1993). Standard

CPR commonly consists of ventilation by intermittent positive pressure via bag-valve or

endotracheal tube and/or mechanical device (Pinchak et al., 1988). Research indicates

that decompression of the chest wall, as occurs during standard CPR, may negatively
alter lung volume capacity, displacing the abdominal contents upward, and thus

decreasing the ventilatory ability (Voelckel et al., 2001). Furthermore, mechanical
ventilation, with its frequent need for high-pressure levels to provide adequate
oxygenation, may injure the lung parenchyma (Adams et al., 2000b, Idris et al., 1996).
The need for both ventilation and chest compression, in bystander CPR, is currently

under debate (Berg, Hilwig, Kern, & Ewy, 1999: Idris, 1995). However, CPR, utilizing

both ventilation and chest compression, remains the treatment of choice (Idris, Wenzel,
Becker, Banner, & Orban, 1995).
Cardiac arrest and CPR result in circulatory impedance and pulmonary hypoxia which
deplete energy and adenosine triphosphate (ATP) levels causing movement of sodium

(Na+), calcium (Ca++), and water (H2O) from extracellular spaces to intracellular spaces,
leakage of potassium (K+) from intracellular spaces to extracellular spaces, and overall

failure of the Na+/K+ membrane pump (Bellamy et al., 1996). Hypoxia leads to oxygen
starvation and cells revert to anaerobic metabolism resulting in lactic acid as a byproduct

(Bellamy et al., 1996). One of the primary causes of cerebral injury is the production of
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lactic acid in brain tissue (Karkela, Pasanen, Kaukinen, Morsky, & Harmoinen, 1992).

Lactic acid binds with calcium causing further depletion in calcium levels. Research has

indicated that postcountershock rhythm disturbances occur, during CPR, in hyperkalemic
and hypocalcemic states and that these disturbances decrease chances for successful

resuscitation (Neiman & Cairns, 1998).
pGz Resuscitation
The pGz motion platform is a new noninvasive approach to cardiopulmonary

resuscitation currently under investigation at the Harry Pearlman Research Center in
Miami Beach, Florida. The pGz method is based on a horizontal foot to head direction or

“z-plane” fluctuation with alternating and periodic acceleration-deceleration platform

movement as occurs when using swine for study (Adams et al., 2000b). Variations are
made in the speed, frequency (0.5-10 Hz), and intensity (0.1-1.5 G.) of the platform’s

motion (Adams et al., 2000a). The pGz platform moves the animal’s entire body, which

produces inertial energy and stimulates both cardiovascular and pulmonary function
(Adams et al., 2000a; Adams et al., 2000b). The force of the acceleration-deceleration
motion drives the abdominal contents toward the diaphragm and results in negative

pleural pressure ventilation similar to human respiration (Adams et al, 2000b). These

periodic movements also produce vascular flow and pulsatile shear stress, to arterial and
capillary walls, and possibly stimulate the production of NO (Adams et al., 2000a;
Adams et al., 2000b).
Adams and associates (Adams et al, 2000a; 2000b; 2001a) have performed several

swine studies using the pGz platform device. Study findings suggest that by manipulating
the acceleration and frequency of inertial forces, noninvasive ventilation of an animal can
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be supported at continuous positive airway pressures as opposed to intermittent positive
pressure commonly associated with standard CPR (Adams et al., 2000a). Additional
experiments were performed to investigate the effects of the pGz motion on meconium

aspiration in pigs (Adams et al., 2000b). Results indicate that this form of ventilation

attenuates the pulmonary hypertension and systemic vascular resistance that frequently

accompany meconium aspiration conditions (Adams et al., 2000b). Once again, this
attenuation of pulmonary and vascular resistance may be due to the hemodynamic vessel

shear stress, and subsequent increase in NO production, as possibly induced by pGz

motion (Adams et al., 2000b; 2001a). Finally, in an experiment on pGz as a form of CPR,
evidence supports the hypothesis that pGz alone produces sufficient capillary circulation

and oxygenation, to both myocardial and cerebral tissue, to maintain a fibrillating animal
for eighteen minutes with post resuscitation arterial blood gases similar to baseline values

(Adams et al., 2001a).
Nitric Oxide

Nitric oxide (NO) is a colorless, odorless, free radical gas and reactive molecular
messenger that diffuses easily across the cell membrane and has a short half-life (2-30

seconds) (Berkels, Purol-Schnabel, & Roesen, 1999; Mossad, 2001). Formerly known as
endothelial relaxing factor (EDRF), NO was identified in the 1980s as an important

biological mediator with multiple actions (Furchgott, 1993). Nitric oxide is produced in
the vascular smooth muscle endothelium, as well as other biological tissues, and the

synthesis of NO is activated by a group of enzymes known as NO synthases (NOS) (Liao,
1999). These enzymes catalyze the conversion of the amino acid L-arginine to L-

citrulline and NO in the presence of oxygen (O2) and require reduced nicotinamide
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adenine-dinucleotide phosphate (NADPH) for optimal function (Vanhoutte, 1999). A

product of the urea cycle, L-arginine circulates in the blood until actively transported into
the cell (Harrison, 1997). Once produced, NO activates guanylate cyclase in the

endothelium and increases cyclic 3’-5’-guanosine monophosphate concentrations

(cAMP) which mediates relaxation in vascular smooth muscle (Lushcer, Boulanger,
Yang, Noll, & Dohi, 1993). The formation of cAMP also inhibits endothelin, a vasoactive

contracting factor produced in the endothelium (Luscher et al., 1993). Therefore, NO is a
potent endogenous vasodilator (Furchgott, 1999). In addition, large amounts of NO are

found in the central and peripheral nervous systems and skeletal muscle (Christopherson
& Bredt, 1997). In these areas, NO is thought to modulate neuronal activity,
gastrointestinal motility, regional blood flow, neuroendocrine actions, behavioral and

memory function, as well as, muscle metabolism and contractility (Christopherson &

Bredt, 1997).
Three isoforms of the enzyme NOS have been identified and include: (1) neuronal

tissue synthase (nNOS or NOS 1), (2) cytokine inducible synthase (iNOS or NOS2) and,
(3) large vessel endothelial synthase (eNOS or NOS3) (Kelly et al., 1996). The action of

all three isoforms depends on the binding of calmodulin, an intracellular protein that

combines with calcium to stimulate various physiological responses (Kelly et al., 1996;
Thomas, 1993). Neuronal (nNOS) and endothelial (eNOS) are constitutive and calcium

sensitive, with calmodulin binding regulated by intracellular concentrations of calcium

ions (Kelly et al, 1996). Conversely, the inflammatory mediated cytokine inducible NOS
is not dependent on calcium as its calmodulin remains tightly bound without regard to

calcium concentration (Kelly et al, 1996). Additionally, the level of NO, by itself, is
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thought to play a role in the regulation of NOS activity (Kelly et al, 1996). Due to the
complexity of the subject matter, this paper will deal primarily with endothelial NOS and

the possible increase in NO production during resuscitation.

The vascular endothelium produces two types of constitutive NOS, basal and
stimulated. Basal production of NO is continuous; however, various agonists such as:

receptor dependent (acetylcholine (ACh), adenosine triphosphate (ATP), and bradykinin)

and receptor independent (Ca++ ionophore and Ca++ ATPase inhibitor) can stimulate the

production of NO (Busse et al., 1993). Increased NO production can also be stimulated
by hypoxic events (decreased arterial PO2), as well as, physical stimulation (fluid shear

stress or pulsatile stretching of the vessel) (Busse et al., 1993). Hemodynamic shear

stress, as produced by increased vessel blood flow, has been implicated in the increased
production of EDRF/NO and subsequent vascular relaxation (Miller, Aarhaus, &

Vanhoute, 1986). In addition, the short half-life of NO is thought to impact numerous

biological processes and results from NO’s rapid destruction via three major reactions:
(1) reaction with oxyhemaglobin or oxymethaglobin to produce nitrite/nitrate, (2) binding

with ferrous heme iron of guanylate cyclase or other proteins, and (3) the scavenging by

superoxide anion (SO) to form peroxynitrite anion (ONOO ) during oxidation (Beckman,
1996). Peroxynitrite is a potent oxidant and may be responsible for neural injury in

cerebral ischemia and reperfusion (Liao, 1999). However, endothelial cells also produce

an enzyme, identified as superoxide dismutase (SOD), as a defense against SO’s rapid
destruction of NO and the consequent cell damage (Mugge, Elwell, Peterson, & Harrison
1991). Research has indicated that fluid shear stress may increase the production of

cytosolic copper/zinc SOD (Cu/Zn SOD), and endothelial NOS, thus increasing the half
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life and protective properties of NO (Inoue, Ramasamy, Fukai, Nerem, and Harrison,
1996).

Furchgott and Zawadzki (1980) first reported the discovery of EDRF after performing

an experiment on rabbit thoracic aorta endothelial cells which suggested “the obligatory
role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine”

(Furchgott, 1993). Furchgott and associates (1986) further experimented with rabbit
aorta, theorizing that EDRF might be the same substrate as NO. Thereafter, EDRF and

NO were compared via perfusion bioassay procedures in numerous studies such as the

experiments by Ignarro et al., (1987) using bovine pulmonary vessels and by Palmer,

Ferrige, and Moncada (1987) using cultured porcine aortic endothelial cells. These
studies also indicated that the chemical characteristics of NO and EDRF were similar, if
not the same (as cited by Furchgott, 1999).

Mugge, et al., (1991) conducted a study on the activation of EDRF/NO by the oxygen

derived free radical superoxide dismutase. Experiments were performed to determine the
existence of endothelial cell defense mechanisms, such as SOD’s scavenging of

superoxide anions, by impairing antioxidant defenses in normal vasculature tissue using
rabbit aorta in vitro and cultured bovine aortic endothelial cells (BAEC). Endothelium

dependent and independent relaxation was measured in the rabbit aorta both before and
after inhibition of Cu/Zn SOD with diethyldithiocarbomate (DETC). SOD activity was

visualized by Beauchamps and Fredovich (1971) assay with enzyme activity indicated by
the appearance of achromatic bands. Results revealed that aortic preparations incubated
with DETC diminished the Cu-Zn SOD activity, as well as, the vasodilator activity of

BAEC effluent, and the NO recovered from that effluent, under basal conditions when
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measured by bioassay. Experiments were also performed using stimulation by various
agonists. Decreased vasodilatation, in the DETC model, was evident after bradykinin

stimulation. Furthermore, results suggest that inhibition of Cu-Zn SOD, with DETC,
diminished both endothelial dependent and independent relaxation and indicate that Cu-

Zn SOD is a necessary component in the production of EDRF/NO (Mugge et al., 1991).

In a study by Inoue, Ramasamy, Fukai, Nerem, and Harrison (1996) the effect of
laminar shear stress on the expression of Cu-Zn SOD, in cultured human aortic
endothelial cells and vascular smooth muscle cells, was examined. These cells were

grown to confluence and placed in a flow chamber with two reservoirs. The temperature

and pH of the fluids was kept constant at a respective 37 °C and 7.4 pH with shear flow
rate regulated by the height of the reservoirs. Western analysis was performed with a

sheep antibody against human Cu-Zn SOD and enzyme activity was assayed. Data was

obtained from the shear and control groups with comparisons made by paired t-tests and
ANOVA with Fischer's least significant difference post hoc test. Results indicated that

steady fluid shear stress at 15 dynes/cm2, for either 24 or 48 hours, showed an increase in

Cu-Zn SOD mRNA transcription, protein, and enzyme activity in human aortic
endothelial cells but no increase was detected in human vascular smooth muscle cells.

These results suggest that Cu-Zn SOD increase may be endothelial specific and that
enhanced endothelial dependent relaxation in vessels denuded by shear stress may be
induced by SOD. Results also suggest that SOD may synergistically stimulate the
vasodilatory properties of endothelial NO (Inoue et al., 1996).

Earlier research on the mechanism of shear stress as involved in the regulation of

endothelial cell NOS mRNA expression was performed by Uematsu et al. (1995). The
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study utilized both bovine aortic endothelial cells (BAEC) and human aortic endothelial
cells (HAEC) and investigated the effects of shear stress on eNOS mRNA, protein
expression, and endothelial cell NO production. NOS activity was measured by

examination of the production of nitrite, a byproduct of NO, in the sheared versus the
control groups. Cells were grown to confluence and exposed to shear forces as delivered
via a flow chamber similar to the Inoue study (1996). However, in this study fluid

temperature was maintained at 37 °C with a pH of 7.2. Similarly, shear stress was set at

15 dynes/cm2 and measured from 1 to 24 hours. Significant results were obtained at 3
hours. Nitrite was converted to NO gas and measured via a chemiluminescence analyzer,

which was appropriately calibrated. Results indicated that increases in eNOS mRNA

occurred at 3 hours in both BAEC and HAEC. Results also suggested an increase in

shear-induced production of NO approximately two-fold in BAEC in both basal
conditions and with administration of the agonist, calcium ionophore. Additional study

data indicated that these increases might be initiated by the opening of K+ channels.
Study findings conflict with earlier research studies that described eNOS as a constitutive

or static enzyme (Uematsu et al., 1995).

In an experiment by De Keulenaer et al., (1998) on the redox state of cultured human

umbilical vein endothelial cells, after either low pulsating oscillatory flow shear stress or

steady laminar flow shear stress, was investigated. Once again, flow chambers were used
to produce shear stress with modifications of lower flow and intermittent pulsatile action
in the oscillatory model. Appropriate fluid temperature and pH were maintained. Changes

in Cu-ZN SOD, presumed adaptive in oxidative stress, were measured via Northern Blot
analysis after endothelial cell exposure to oscillatory shear flow (5 dynes/cm2, 1 Hz) at
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intervals of 1, 5, and 24 hours. In this experiment, no change was evident in the level of
Cu-Zn SOD. Conversely, when endothelial cells were exposed to steady laminar shear

flow (5 dynes/cm2) for 24 hours, Cu-Zn SOD mRNA and protein levels were increased.
Oxidative stress was also investigated in measurements of NADH oxidase, intracellular

O2 levels, and heme-oxygenase-1 (HO-1). Intracellular oxygen (O2) was measured after

both oscillatory and laminar shear stress and O2 levels were found to be three times

higher in the oscillatory model. Study findings are consistent with previous research

indicating that increases in Cu-Zn SOD, and accompanying protective antioxidant
properties, may be stimulated by shear stress. However, these findings suggest that

increases in Cu-Zn SOD may be laminar shear specific (De Keulenaer et al., 1998).

In a study by Schleien et al., (1998) experiments were done to examine whether the
increases in NO activity associated with cardiac arrest, CPR, and reperfusion might be

detrimental in relation to successful resuscitation. This study examined the inhibition of
NO activity by N-nitro-L-arginine methyl ester (L-name; 3 mg/kg) and tested the

hypothesis that such inhibition would (1) lessen cerebral and cardiovascular hyperemia,

(2) benefit vascular effects on other organs allowing for successful resuscitation and
reperfusion, and (3) maintain cerebral oxygen and glucose rates without altering lactate
production by the lessened blood flow after resuscitation. The study measured vascular
pressures, regional blood flow, and cerebral metabolism before, during, and after CPR on

anesthetized pigs via aortic, right atrial, pulmonary artery, and sagittal sinus pressures,

arterial blood gases, and plasma glucose and lactate concentrations. Study findings
indicated that (1) L-name did not decrease cerebral or myocardial flow or adversely
affect the rate of successful CPR, (2) L-name lessened cerebral hyperemia, and (3) L-
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name decreased cardiac output before and after arrest. L-name was believed to have a

negative inotropic affect on cardiac function. Study results also suggested that possible

adverse affects in cerebral and cardiac function, as well as decreased circulation to the
kidneys and other organs, might result from the attenuation of cerebral and
cardiovascular hyperemia (Schleien et al., 1998).
NO and Anesthesia

Although controversial, research studies indicate that the NO/cGMP pathway plays an
important role in maintaining consciousness and facilitating nocioception, whereas the
inhibition of NOS maybe responsible for sedation and analgesia (Fukada et al., 1999;
Tonner et al., 1999). Moreover, the action of certain anesthetics on NO production and

inhibition may account for the variability found among numerous studies investigating

the properties and production of NO (Galley, Cras, Logan, & Webster, 2000). Evidence

exists suggesting that NO has a dual action of either nociception or antinociception

dependent on the tissue site where it’s found (Lauretti, Oliveira, Juliao, Reis, & Pereira,

2000; Lauretti, Oliveira, Reis, Mattos, & Pereira, 1999). In fact, NO appears to inhibit
pain perception in the descending spinal pain pathway and may act directly on mu opiod

receptors enhancing their effect (Lauretti et al., 1999; 2000). The NO pathway is the
foundation for the pharmacodynamics of certain nitrate medications such as
Nitroglycerin, Sodium Nitroprusside, and Hydrazaline (Morgan, Mikhail, & Murray,

2002). Nitroglycerine patches have been shown to have a possible synergistic effect when
administered with intrathecal neostigmine in gynecological surgeries, with intrathecal

sufentenil in orthopedic surgeries, and with morphine administered either by intrathecal

or intravenous methods (Lauretti, 1999; 2000). This synergistic effect helps delay the
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need for post-operative rescue pain medications for up to 14 hours (Lauretti et al., 2000).

Additionally, the neurotransmitter and intracellular messenger properties of NO may
influence some of the systemic effects of local anesthetics such as: cardiac depression,
cardiac arrhythmias, and grand mal seizures (Heavner, Shi, & Pitkanen, 1999). The

cardiotoxicity of lidocaine, a commonly used antiarrythmic, and anesthetics such as:

tetracaine and cocaine appear attenuated with NO inhibition (Heavner, Shi, & Pitkanen,
1999; Roig et al., 2000). Research indicates that adverse alcohol withdrawal symptoms
are also decreased with the inhibition of NO and this result may have important treatment

ramifications (Adams & Cicero, 1998). Some studies suggest that Halothane, formerly
one of the most frequently used volatile anesthetics, alters the NO pathway via inhibition
of calcium release from both the sarcoplasmic reticulum and the calcium release induced

by bradykinin (Galley et al., 2001; Fukada et al., 1999; Loeb, Raj, & Longnecker, 1998;

Tsuchida, Tanaka, Seki, Inoue, & Namiki, 1999). Both types of calcium release are
necessary for NO production as eNOS and nNOS are calcium dependent (Tsuchida et al.,

1999). Halothane and isoflurane, when administered with a NO inhibiting agent such as

L-NAME, may decrease the threshold for minimum alveolar anesthetic concentration
(MAC) by blocking the NO pathway at the level of cGMP (Fukada et al., 1999; Galley et

al., 2001). Research indicates that inhaled NO is also a potent selective bronchodilator
and is commonly administered by anesthesia machines to treat pulmonary hypertension
and hypoxia during surgery (Ceccarelli et al., 2000). Obviously, understanding the
stimulation and inhibition of NO production may have important implications regarding

the dosage and route of many anesthetics, pain treatment modalities, and research study

modifications.
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The review of the literature on nitric oxide research reveals evidence that NO and

EDRF have the same chemical characteristics. Study findings indicate that NO and SOD
are both products of endothelial and laminar flow sheer stress. Research also proposes

that Cu-Zn SOD is an important component in the biological synthesis of NO and in

scavenging super oxide anions that limit NO’s effect. Study results indicate that the
release of SOD, and its stimulation of NO, may be laminar sheer flow specific. Although,

research (De Keulenaer et al., 1998) proposes a difference between steady laminar and

low flow oscillatory shear stress and the resulting stimulation of Cu-Zn SOD or NO
production, the magnitude of the flow force produced by pGz motion is thought to
produce hemodynamic shear stress and pulsatile vessel stretch during pGz resuscitation

(Adams et al., 2001a). Additionally, research opposes the previous held belief that eNOS

is a constitutive or static enzyme. Research findings on the inhibition of NOS show this
effect to reduce hyperemia, in cerebral and cardiovascular tissue, but whether this

attenuation is beneficial during cardiac arrest is questionable. Variability among NO

studies may be explained by the inhibition or stimulation of NO by certain anesthetic
agents. Finally, a great deal of evidence exists suggesting that NO release may be induced
by fluid and pulsatile shear stress. Furthermore, the strong evidence reported here

supports the researcher’s proposal to study the effect of pGz platform motion on NO
levels and to determine whether a related increase in NO levels occurs during

resuscitation in anesthetized pigs.
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3. Methodology

Introduction

Research studies investigating resuscitation using standard CPR methods suggest that
standard CPR produces a variety of physiological responses, many of which are
detrimental to successful resuscitation outcomes. The pGz model is a new form of
resuscitation procedure devised with the hope of possibly decreasing resuscitation
mortality rates. The free radical NO is thought produced during hypoxia, ischemia, and

hemodynamic shear stress events and therefore a possible byproduct of resuscitation

procedures. This study was designed to investigate the effects of pGz motion platform

resuscitation on the production of NO in anesthetized pigs. The production of NO was
measured at baseline and at 10-minute intervals during resuscitation using the pGz

model. Nitric oxide measurements were compared between the two models, pGz and
standard CPR.
The foundation for the proposed hypotheses to be studied was based on a theoretical

framework created from previous research findings as cited from studies examining

standard CPR and pGz methods and the induced production of NO. The study attempted
to determine if (Hi) there is a difference between NO levels during pGz resuscitation and
baseline levels prior to pGz resuscitation, if (Hi) there is a difference between NO levels

during standard CPR and baseline levels prior to standard CPR, and if (Hi) the NO levels
are greater during pGz resuscitation than during standard CPR. Basic to the study

framework was the theory that NO production is stimulated by various vasomodulators,
namely hemodynamic shear stress and pulsatile vessel stretch. The movement of the pGz

platform was assumed to produce both of these vasomodulators during the resuscitation
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of anesthetized pigs and consequently an increase in NO production is expected to
follow.

Design

The study used an experimental repeated measures design to determine the possible

increase in NO levels in anesthetized pigs during pGz and standard CPR resuscitation. A

total of twelve pigs was used in the study and divided into two groups of 6 pigs each. In

order to test the study hypothesis, two experiments were performed: (1) measurement of
NO production during pGz resuscitation, and (2) the measurement of NO production

during standard CPR resuscitation. Comparisons were be made between the two levels.
Variables and Measurements

Independent Variables

pGz. Periodic acceleration (pGz) refers to a novel method of resuscitation, which uses
a motion platform device, to move an animal in a footward to headward direction, with

the purpose of ventilating and stimulating cardiovascular circulation in anesthetized and
arrested pigs. The frequency of acceleration and deceleration movements ranges from 0.5
- 10 Hz at a force of 0.1 - 1.5 G. Approximation of heartbeat per minute (bpm) to

corresponding frequency of motion is 1 Hz = 60 bpm (Adams et al., 2001a). Ventilations

occur via the force of acceleration movement, which thrusts the animal’s abdominal
contents toward the diaphragm and produces negative pleural pressure respiration

(Adams et al., 2000b).
Platform design. The motion platform design (Adams et al., 2000a) is as follows:

The motion platform was constructed around a linear displacement current motor

(Model 400, 12 volt; APS Dynamics, Carlsbad, CA). The motor is powered by
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dual-mode power amplifier (model 144, APS Dynamics) connected to a sine

wave controller (model 140-072; NIMS, Miami Beach, FL). The controller allows

for the control of the frequency of the table oscillation, the amplitude of the voltage
reaching the motor and subsequent acceleration of the stroke, and the duty cycle of

the motor. The motor is secured in the bottom and center of a frame constructed

from treated pine lumber. The table platfrom is directly driven by the underlying
motor and articulates across the frame on stainless steel tracks and nylon wheels.
The unit has a maximum weight capacity of ~30 kg and operates at a frequency of

0.5 - 10 Hz at a force of 0.1-1.5 G (Adams et al., 2000b, p. 2448).
Standard CPR. Standard CPR refers to external closed chest compressions and

ventilation. Standard chest compressions refer to “external closed chest compressions
applied to an area of the chest approximately the size of the heel of an adult’s hand”
(Idris et al., 1996, p. 529). Chest compressions were done via the Thumper, “. .. a

mechanical deice for compressing the chest in a uniform, repetitive fashion with constant
rate and force” (Pinchak et al., 1988). Standard CPR is commonly performed at a rate of

15 compressions to 2 ventilations manually (approximately 80-100 bpm).
Ventilation. Ventilation refers to “any movement of gas in and out of the lungs” (Idris

et al., 1996, p. 529). Ventilation includes intermittent positive pressure via bag valve,
endotracheal tube, mechanical ventilation, and gas movement resulting from chest

compression or pGz platform movement.
Dependent Variable.

Nitric Oxide (NO). NO is a colorless, odorless, free radical gas that is produced in the
vascular endothelium, and in other biological tissue sites, in response to such stimulants
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as hypoxia, ischemia, hemodynamic shear stress, pulsatile vessel stretch, and receptor

dependent and independent agonists (Busse et al., 1993; Miller et al., 1986). Normal or
basal levels for NO were not found in the literature; therefore, NO will be measured with
baseline levels used as control. NO levels are dynamic with baseline levels specific to

each individual pig. NO measurements were made using the Isolated Nitric Oxide Meter
and Sensors (ISO-NO Mark II; World Precision Instruments Inc., Sarasota, FL, 2000).
ISO-NO Mark II. The ISO-NO analyzer (WPI, 2000) is a highly sensitive

instrument for the measurement of NO in biological tissues. NO is measured via the

reduction of nitrate/nitrite, the byproducts of NO, to NO using an amperometric sensor
(2.0 mm) (Berkels et al., 2001). The ISO-NO analyzer has the ability to measure basal

and agonists stimulated NO production in both aqueous solutions and gas mixtures. First,

nitrate is converted to nitrite via an enzyme (nitrate reductase) and then nitrite is reduced
to NO using an acidic solution (Berkels et al., 2001). The detection limit of nitrite is as

low as 1 nM when using the ISN-NO sensor electrode (WPI, 2000). The electrode has a

membrane cover which NO diffuses through producing an electrical current proportionate

to the NO concentration of the specimen (WPI, 2000). Accuracy of measurement is based
on correct calibration of the instrument using a titration method (nitrite in the presence of
H2SO4 and KI) (WPI, 2000). Accurate calibration requires construction of a standard
curve to determine sensitivity of the sensor (slope of the standard curve) precisely as

noted by pA/nM NO (WPI, 2000). The ISO-NO 2.0 sensor electrode can be used to

measure NO reduced from nitrate/nitrite and NO concentration in cell cultures and
sensitivity is 2 pA/nM (WPI, 2000). Numerous publications citing the validity, reliability,
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and sensitivity of the ISO-NO Mark II instrument, relating to measurement of NO

production during experimental studies, are available (WPI, 2000).
The principle investigator received training, along with other pGz research

investigators, in NO measurement using the ISO-NO Mark II instrument. Training
included a session with the WPI ISO-NO representative and took place at the Mount

Sinai Research facility. Training required approximately a one-month period of 2-3 days
a week.
Control Variables

Arrest. Arrest refers to cardiac arrest or “the cessation of cardiac mechanical activity”

as indicated by the “sudden loss of arterial pulsations on intravascular pressure monitors
and a systolic aortic blood pressure of < 25 mmHg” (Idris et al., 1996, p. 529).
Cardiac arrest will be induced via the stimulation of ventricular fibrillation using a

bipolar wire placed at the apex of the heart and delivering 30 V of A.C. current at 60 Hz

(Adams et al., 2000, 2001a). All animals under study had induced ventricular fibrillation.
Sample Selection. The use of a randomly selected homogenous breed of animals in

this study was used as a sample control. The swine model is commonly used in CPR
research due to the similarity of metabolic processes, cardiovascular functions, and

coronary anatomies between swine and human populations (Idris et al., 1996). In

addition, juvenile pigs are noted as a homogenous breed due to similarity in size and
structure at corresponding ages and weights (Idris et al., 1996).

Baseline: Baseline measurements of NO concentrations were used as control in the

within group experiments. Baseline refers to “conditions attained before induction of
cardiac arrest, usually in an anesthetized, intubated, ventilated, and instrumented animal.
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They do not represent the normal physiological state of an animal subject” (Idris et al.,

1996, p. 528).
pGz manipulation. The frequency and force of the pGz motion platform movement
were used as a control with frequency set at 2 Hz (approximately 120 bpm) and the force

set at 0.6 G for all experiments (Adams et al., 2000b; 2001a).

Data Collection

The first experiment (n=6) measured the production of NO, as obtained from serum
specimens, at baseline and at 10-minute intervals (x 2) during pGz resuscitation. The

second experiment (n=6) measured the production of NO levels, as obtained from serum
specimens, at baseline and at 10-minute intervals (x 2) during standard CPR resuscitation.
Comparisons were made between the pGz and standard CPR groups measured serum

levels of NO concentration (Figure 3-1). The serum specimens obtained consisted of

whole blood, collected at the previously stated times, which was quickly centrifuged and

frozen for later analysis. Serum levels of NO were measured, via the presence of nitrate
concentrations, using three modalities: (1) reductase method using the ISO-NO Mark II
instrument, (2) deproteinization method using the ISO-NO Mark II method, and (3) assay

quantification via the Greiss reaction using a reductase specimen.

Measurement Techniques

The measurement of serum NO levels via the ISO-NO Mark II Analyzer was
performed using two different measurement methods. The first method using the

reductase preparation was performed after first preparing nitrate standards to ensure
internal control in a graduated fashion from 0 uM to 500 uM. Biological NO is rapidly

oxidized to nitrite and nitrate. As nitrite concentration is the preferred serum
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Figure 3-1. Study Protocol

measurement, thawed room temperature serum NO samples were reduced from nitrate to
nitrite by treating the samples with cooperized cadmium pellets (Cd-Cu) that were

washed with both cleaning and IX buffer solutions. These solutions were removed via a
pipetting technique. The NO serum sample and a 3X buffer were added to the specimen

tubes containing the remaining Cd-Cu Reducer pellets, shaken for 25 minutes and
centrifuged for an additional 5 minutes. The second ISO-NO Mark II Analyzer method,

deproteinization, used the above reductase preparation after two additional solutions were
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added to remove protein. The same procedure for the preparation of internal control

standards was used as in the reductase preparation. Serum NO was also quantified using a

Greiss reaction on reductase samples, prepared as described earlier, and the Greiss assay
carried out in a 96-well microtiter plate format. The Greiss reaction assay was then read
in a microtiter plate scanner at 540nm, with water as the reference, and had a sensitivity

of 10.6 uM. Internal control was also established using known amounts of sodium nitrite
in a graduated fashion and via a standard curve.

Sample
Twelve randomly selected juvenile piglets (9.5 + 12.09 kg) were used for this study

and were provided by a grant from Miami Heart Institute and housed at the Harry
Pearlman Research Institute at Mount Sinai Medical Center. The swine model used in the
study was presumed free of any pathology.

Estimation of Sample Size

A sample of two groups of 6 piglets each was used in the study. This sample size was

based on previous studies using the pGz model, Utstein guidelines, provisions of Miami
Heart Institute, and was appropriate for a pilot study for feasibility. The pGz experiments,
on the production of NO in anesthetized pigs, is part of an ongoing study on various

biological responses during pGz resuscitation currently in progress at the Mount Sinai

Research facility.
Ethical Considerations
The principle investigator completed the animal certification course as required by the
Institute for Animal Care and Use Committee (IACUC) and approved by Mount Sinai

Medical Center-Miami Heart Institute and Florida International University. The research
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protocol was performed and reported per compliance with the Utstein-Style Guidelines

for Uniform Reporting of Laboratory CPR Research, the Animal Welfare Act, and any

other public laws and regulations as are appropriate. The use of a swine model allowed

for necessary invasive procedures, stimulation of ventricular fibrillation, and performance
of subsequent resuscitation processes as were needed to complete the experiment. The
animals were housed and cared for at the Mount Sinai Research facility in the appropriate

manner. The experimental procedures utilized during the study endeavored to minimize

both animal use and frequency of invasive procedures. At the completion of the

experiments, all animals that survived were euthanized by a lethal barbiturate dose as per
IACUC requirements.

Animal Preparation
The preparation of the study animals was performed using the protocol of previous

pGz experiments (Adams et al., 2000a; 2000b; 2001a). Animals under study were

anesthetized with Ketamine (lOmg.kg, I.M.) prior to entering the research laboratory

procedure site. Additional Ketamine was administered prior to invasive procedures and
the animals were held in a surgical plane of anesthesia with an intravenous Diprivan and
Ketamine combination. Paralysis was induced via Pancurium Bromide at 0.1 mg/kg with

continued supplementation as needed. The depth of anesthesia was determined by loss of
the corneal and spinal reflex with accompanying animal heartbeat of 150 bpm (Adams et

al., 2000a; 2000b; 2001a).
Prior to pGz movement or standard CPR procedures, the animals were intubated via

an endotracheal tube and the femoral artery was cannulated to facilitate the procurement
of arterial blood specimens, arterial blood gases, and arterial blood pressure
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measurements. An electrocardiogram continuously monitored the animals’ heart rhythm
and the animals received 100% O2 with 5cmHg CPAP in order to reduce hypoxic

consequences. Additionally, a right atrial catheter was placed in the internal jugular vein
and used for administering fluids and medications and measuring right atrial pressure. All
invasive catheters were sized according to animal anatomical requirements. A bipolar

fibrillating wire was placed at the apex of the heart and this was used to induce
ventricular fibrillation in the study animals. Stimulation of ventricular fibrillation was

initiated via delivery of 30 volts of A.C. current at 60 Hz (Adams et al., 2000a; 2000b;
2001a).
The animals were placed on the motion platform with extremities bound in order to

maintain close approximation with the platform device. The platform moved in a cephalic

foot to head direction with periodic accelerations and decelerations. This motion allowed
for manipulation of the speed and frequency of oscillations (Adams et al., 2000a; 2000b;

2001a).
Method of Data Analysis
The repeated measures non-parametric experimental design for the within group

experiments (77i), and the between group comparison (7/2), was performed using various
statistical methods. Originally, a repeated measures two-way ANOVA was the statistical

analysis chosen for the study as this design is a robust parametric method that allows

multiple values to be obtained from the same animal, using the animal as its own control,

and ensuring a high amount of equivalence among the study subjects (Polit & Hungler,
1999). Parametric statistical methods are used to analyze experimental studies for

examining causality but must have three essential elements: (1) random sampling, (2)
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manipulation of the independent variable, and (3) control of the experiment (Burns &

Grove, 1993). The decision to use a non-parametric statistical method was reached once

it became evident that the criteria for parametric testing was not met. Parametric testing
infers the following assumptions: (1) a normally distributed population in which the

variance can be calculated, (2) an interval or ordinal level of study data available, and (3)
the available data appropriate for use as random samples (Burns & Grove, 1993). The
appropriateness of parametric testing for this study was evaluated via the following

analysis. First, a Mauchly’s test of sphericity was performed with the results indicating

the assumption of symmetry met and suggesting a univariate approach appropriate. The

Greenhouse-Geiser and Huynh-Felt tests, used for correction of compound symmetry for

repeated measures ANOVA, were also performed but here the criteria were not met. At
this point, the repeated measures ANOVA parametric design was deemed inappropriate
for use in this study. Next, the Kolmogorov-Smirnov test for normality was performed

showing an abnormal distribution, based on the sample size, and indicating the need for
nonparametric testing. The nonparametric test chosen for the study was the Friedman

matched samples, which parallels repeated measures ANOVA in populations lacking

normality. In the samples where Friedman showed significance, the non-parametric
Wilcoxon signed ranks test was chosen to evaluate changes in pretest (baseline)/ posttest
(10 minute intervals). Both the magnitude and direction of the change can be measured

by the Wicoxon design and the signed-ranking is particularly useful in studies where

negative values (decreases in NO levels) are possible. The Kruskal-Wallis test was used

to compare the two groups (pGz and standard CPR) and is the most powerful
nonparametric one-way ANOVA to detect differences between groups while testing the
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null hypothesis that all samples are from the same population (Burns & Grove, 1993). For
the non-parametric tests, Kruskal-Wallis signed ranks and Friedman matched samples,

scores were converted into ranks with the analysis comparing the mean ranks in each

group.
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4. Results

This study examined the effects of intraoperative resuscitation, via pGz or

standard CPR, on the production of NO. Twelve randomly selected juvenile pigs, ranging
in weight from 9.5 to 12.0 kg were used in both experiment sets of this study. Data were
analyzed using nonparametric tests using a univariate approach. Based on the results of

the Mauchly’s test of sphericity, the assumption of compound symmetry was met;

therefore, the univariate approach was used. All data analyzed failed the test for
normality and the homogeneity of variance requirement was not met. Analysis of
residuals indicated that the assumptions underlying the ANOVA were not satisfied;

therefore, the nonparametric test, Kruskal-Wallis, was used. In addition, overall
resuscitation method, time, and interaction effect were not significant using the

Greenhouse-Geiser and Huynh-Feldt correction for lack of compound symmetry, an
assumption underlying Repeated Measures ANOVA. Therefore, the nonparametric
Friedman matched samples test was used. To reduce the possibility of making a Type I
error, rejecting the null hypothesis when it is true, alpha was set at 0.05 for all hypothesis

tests. To reduce the probability of rejecting the null hypothesis when it is false (Type II

error), power was set at 0.80. A sample size of 12 (6 per group) was used for this study

based on prior studies using the pGz model, Utstein guidelines, provisions of Miami
Heart Institute, and as is appropriate in a pilot study for feasibility. Data were analyzed

using the SPSS statistical software for Windows 7.0 on a PC compatible computer.

Results of Specific Hypotheses
Hypotheses proposed for this study dealt with (a) levels of NO during pGz
resuscitation (Hi), (b) levels of NO during standard CPR resuscitation (H2), (c) levels of
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NO during pGz and standard CPR resuscitation (H3). Results are reported in means and
standard deviations (SD) unless otherwise noted.
Effects ofpGz on NO Levels

Hypothesis 1: There is a difference between NO levels during pGz
resuscitation and baseline levels prior to pGz resuscitation.

Mean scores of NO were compared between baseline levels of NO and NO levels
at 10 and 20 minutes (Table 4-1) (Figure 4-1). Using the reductase method, after pGz

was initiated, NO levels rose to 2.63 (18.80) at 10 minutes, which was not significant

from baseline and at 20 minutes NO levels decreased to -5.13 (11.15), which also was not

significant. Using the deproteinizing method, after pGz was initiated, NO levels
decreased to -4.83 (14.41) at 10 minutes, which was not significant from baseline and at
20 minutes NO levels decreased to -8.97 (13.23), which also was not significant.

However, when the Greiss method was utilized, the decreases in NO levels were
significant at both 10 minutes and 20 minutes. At 10 minutes NO levels were -4.57
(3.68), which was significant at p = 0.046 and at 20 minutes mean NO levels were -6.70
(5.14), which was significant at p = 0.028. There was no significance between 10 and 20
minutes. Therefore, the hypothesis was supported only when the Greiss method of NO

measurement was used.
Hypothesis 2: There is a difference between NO levels during standard CPR

and baseline levels prior to standard CPR.
Mean scores of NO were compared between baseline levels of NO and NO levels
at 10 and 20 minutes (Table 4-1) (Figure 4-2). Using the reductase method, after CPR

was initiated, NO levels decreased to -13.97 (36.07) at 10 minutes, which was not
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Table 4-1. Mean Delta No levels, pGz vs CPR (n = 6)

Reductase

Deproteinizing

Greiss

Time 0

Resuscitation
Method
pGz

Baseline

Baseline

Baseline

10 min

pGz

20 min

pGz

Time 0

CPR

2.63
(18.80)
-5.13
(11.15)
Baseline

-4.83
(14.41)
-8.97
(13.23)
Baseline

*-4.57
(3.68)
*
-6.70
(5.14)
Baseline

10 min

CPR

20 min

CPR

-13.97
(36.07)
-40.45 *±
(37.53)

4.07
(12.22)
-2.46
(17.08)

*
5.34
(7.10)
1.93
(7.95)

Time

This table summarizes the comparisons of the different methods of NO measurement

during pGz and CPR at baseline, 10 minutes and 20 minutes.
* p < 0.05, significantly different from baseline; ±p < 0.05, significantly different from

10 min
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Figure 4-1. Delta NO Means-pGz

Delta NO Means - pGz

Figure 4.1. Within group comparison of NO levels during pGz at baseline (BL),
10 minutes and 20 minutes.

Figure 4-2. Delta NO Means - Thumper

Delta NO Means - Thumper

Figure 4.2. Within group comparison of NO levels during thumper at baseline (BL),
10 minutes and 20 minutes.
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significant from baseline (p = 0.249) and at 20 minutes NO levels decreased to -40.45
(37.53), which was significant (p = 0.028). In addition, NO levels were significantly
different between 10 and 20 minutes (p = 0.028). Using the deproteinizing method, after
CPR was initiated, NO levels increased to 4.07 (12.22) at 10 minutes, which was not

significant from baseline and at 20 minutes NO levels decreased to -2.46 (17.08), which
also was not significant. However, when the Greiss method was utilized, the increases in

NO levels were significant only at 10 minutes with NO levels of 5.34 (7.10), p = 0.028.

At 20 minutes mean NO levels were 1.93 (7.95), which was not significant at p = 0.600.
There was no significance between 10 and 20 minutes. Therefore, the hypothesis was
supported only when the reductase and Greiss methods of NO measurement was used.

Hypothesis 3: The NO levels are greater during pGz resuscitation than
during standard CPR.
Mean rank scores of NO levels were compared between pGz and CPR at 10 and
20 minutes (Table 4-2) (Figure 4-3). Comparing pGz with CPR using the reductase

method, at 10 minutes pGz was ranked at 7.33 and CPR was 5.67, which was not

significant. At 20 minutes, pGz was 8.42 and CPR 4.58, which also was not significant.
Comparing pGz with CPR using the deproteinizing method, at 10 minutes pGz was

ranked at 5.50 and CPR was 7.50, which was not significant. At 20 minutes, pGz was
ranked at 6.00 and CPR 7.00, which also was not significant (Figure 4-4). Comparing

pGz with CPR using the Greiss method, at 10 minutes pGz was ranked at 3.50 and CPR

was 9.50, which was significant (p = 0.004), indicating that CPR NO levels are higher
than pGz levels during resuscitation. At 20 minutes, pGz was ranked at 4.67 and CPR
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Table 4-2. Mean Ranks (n - 6)

Time

Resuscitation
Method
pGz

Reductase

Deproteinizing

Greiss

6.50

6.50

6.50

CPR

6.50

6.50

6.50

pGz

7.33

5.50

3.50

CPR

5.67

7.50

*
9.50

pGz

8.42

6.00

4.67

CPR

4.58

7.00

8.33

Baseline

Baseline

10 min

10 min

20 min

20 min

This table summarizes the ranked comparisons of NO levels between pGz and CPR at

baseline, 10 minutes and 20 minutes.
* p = 0.004, significantly different from baseline
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Figure 4-3. Delta NO Means - Reductase. Thumper vs. pGz.

Delta NO Means - Reductase
Thumper vs pGz

Figure 4.3. Between group comparison of NO levels using reductase measurement.

Figure 4-4. Delta NO Means - Deproteinization. Thumper vs. pGz.
Delta NO Means - Deproteinization
Thumper vs pGz
8
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Figure 4.4. Between group comparison of NO levels using deproteinization measurement.
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Figure 4-5. Delta NO Means - Greiss Assay. Thumper vs. pGz.

Delta NO Means - Greiss Assay
Thumper vs pGz

Figure 4.5. Between group comparison of NO levels using Greiss Assay measurement.

8.33, which was not significant (Figure 4-5). Therefore, the third hypothesis was not

supported.

Major Findings
Differences in serum NO levels from baseline to 10 and 20 minutes, in animals

undergoing pGz resuscitation, were noted as follows: (1) the reductase ISO-NO Mark II
analysis showed a rise in mean NO levels from baseline at 10 minutes and a decrease in

mean NO levels at 20 minutes but neither change was found significant, (2) the

deproteinization ISO-NO Mark II analysis showed a decrease from baseline in NO levels
at both 10 and 20 minutes but these were also without significance. However, when using

a Greiss reaction, with pGz resuscitation serum samples, a significant decrease in mean

NO levels from baseline was noted at both 10 and 20 minutes. Since it was hypothesized
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that there would be a change in serum NO levels from baseline, in animals undergoing
pGz resuscitation, the first hypothesis was only supported in the NO levels measured via
the Greiss reaction. Differences in NO serum levels from baseline to 10 and 20 minutes,
in animals undergoing standard CPR, were noted as follows: (1) the reductase ISO-NO

Mark-II analysis showed a decrease in mean NO levels from baseline at both 10 and 20

minutes, (2) the deproteinization ISO-NO Mark II analysis showed an increase in mean
NO levels from baseline at 10 minutes and a decrease at 20 minutes. Here, the increase in
NO levels at 10 minutes from baseline using the reductase measurement, in animals

under standard CPR, was not significant; however, the decrease in NO levels at 20

minutes from baseline was significant. A significant difference was also noted in NO

levels between 10 and 20 minutes using the reductase method. The deproteinization
method of NO measurement, in animals undergoing standard CPR, did not show
significance in either the 10 minute increase in NO from baseline or the 20 minute
decrease in NO from baseline. When using the Greiss reaction to measure NO levels

from baseline, in animals undergoing standard CPR, a significant increase was noted at

10 minutes. Although an increase in mean NO levels from baseline at 20 minutes was
also noted, it was without significance and there was no significance between the 10 and
20 minute NO levels using the Greiss method. The second hypothesis stated that there

would be a difference between NO levels, during standard CPR, and baseline levels prior

to standard CPR, which was, only supported in NO levels using the reductase method at
20 minutes and between 10 and 20 minutes under ISO-NO Mark II analysis, as well as,

NO levels at 10 minutes using the Greiss reaction. When testing the third hypothesis,
which stated that the NO levels would be greater during pGz resuscitation than during
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standard CPR, the following was noted: (1) when using the reductase measurement the
mean pGz NO levels were greater than CPR at both 10 and 20 minutes but without

significance, (2) when using the deproteinization measurement the pGz NO levels were
less than CPR at both 10 and 20 minutes also without significance, and (3) when using
the Greiss reaction measurement the mean NO levels under pGz resuscitation were less

than CPR at both 10 and 20 minutes with only the 10 minute measurement significant.
Therefore, the third hypothesis was not supported.

Although, significant differences in NO levels from baseline were noted in some of
the reductase, deproteinization, and Greiss reaction methods of measurement, under both

pGz resuscitation and standard CPR, these differences were inconsistent and none of the

hypotheses well supported. These inconsistencies may be due to various factors, such as

flaws with the measurement tools, unknown pathology in the animal, and small size of
the study sample.
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5. Discussion and Conclusion
The basis of this study was a theoretical framework created from the literature review

of research supporting the postulate that the production of NO in pigs can be induced by
shear stress and pulsatile vessel flow as believed to occur during pGz motion platform

resuscitation. In order to support the study hypotheses, animals were studied under two
types of resuscitation, pGz and standard CPR, to determine changes in serum NO levels
from baseline versus NO levels at 10-minute intervals during resuscitation. The changes
in serum NO levels were also compared between the two forms of resuscitation.

Increased production of NO was expected under pGz resuscitation due to the movement

of the motion platform. As pGz resuscitation is a novel approach, not much literature
exits on its effect on physiological responses. Therefore, this study was performed to
determine whether an increase in endogenous NO is actually a physiological response to

pGz resuscitation and whether such an increase in NO is greater in magnitude during pGz
resuscitation than the NO found during standard CPR.

Three hypotheses were tested in this study on the effect of manipulating two types
of intraoperative resuscitation, pGz and standard CPR, on physiological responses such

as endogenous NO levels in anesthetized pigs. In order to test the hypotheses, three forms
of serum NO measurement techniques were used: reductase and deproteinization using

the ISO-NO Analyzer and the Greiss reaction assay using the microtiter plate scanner.
Although each measurement technique showed some changes in NO levels from baseline,

the results were not consistent and none of the hypotheses well supported. In fact,

significant increases in serum NO levels were found during standard CPR contrary to the
expected increase during pGz. The difficulty in accurately measuring a local mediator
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such as NO, found in such small basal quantities with a half-life of 3-5 seconds and that
rapidly oxides to nitrite and nitrate, has been written of in numerous research studies over
the past 20 years (Beckman, 1996; Berkels et al., 1999; Palmer, Ferrige, & Moncada,

1987). Therefore, to have found any difference in NO levels from baseline in this study is

believed to be extremely promising. Possible explanations for the variations in the study

results will be addressed in the following discussion.
Discussion

Hypothesis 1 postulated that there would be a difference between NO levels during

pGz resuscitation and baseline levels prior to pGz resuscitation. The hypothesis was not
supported. Results from the present study indicate that mean NO levels were decreased at
both 10 and 20 minutes when measured via the Greiss reaction but no significance was
found utilizing the other two measurement techniques (reductase and deproteinization)

when using the ISO-NO Analyzer. As previously mentioned, measuring NO is extremely

difficult and the inconsistency in the results may result from factors such as the extremely

short half-life of NO in biological systems (3-5 seconds). Another possibility may be
related to the use of serum samples rather than cell cultures as a medium. All the research
cited in the literature review was performed using cell cultures and studies that measured

NO utilizing only serum samples were not found. However, Adams et al (2001) found
increased serum NO levels during their studies on regional blood flow during pGz

resuscitation. In Adams experiment, NO was measured via the Greiss reaction but
utilized a different reduction (nitrate to nitrite) modality than was used in the current
study. The quantification of NO via reductase or deproteinization methods using the ISO

NO Analyzer or measurement of NO via the Greiss method requires the reduction of
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nitrate to nitrite. This reduction is accomplished by treating the samples with metals, such
as cadmium or zinc, or by using reductase enzymes (Beckman, 2001). The current study

utilized cadmium (Cd-Cu Reducer), which depends on factors such as time, surface area,

sample volume ratio, temperature, and pH for conversion ability (WPI, 2001).
Alterations or inconsistencies in any one of these factors may interfere with accuracy.

Although a deproteinization method was used to avoid the deposition of proteins and/or
particulate substances on the reducer surface, this may be another possible reason for

inaccuracy in the NO results. Preparation of the Cd-Cu Reducer also requires a buffering
agent, that may possibly become contaminated with transition metals, iron or copper and

which may bind and deactivate NO. Contamination with 02 has also been cited as

problematic when transferring NO samples in syringes (Beckman, 1996). In the study by
Adams, the reduction method employed was diazotization with 1% sulfanilamide in 30%
acetic acid and Azo coupling performed combining the diazo product with an equal

volume of 0.1% N-(l-napthyl) ethyldiamine hydrochloride in 60% acetic acid (Adams et
al, 2001). This may be a better method of NO reduction when utilizing a Greiss method

of measurement in future studies.
Another possible explanation for the decrease in NO during pGz resuscitation is the

effect of reperfusion injury as occurs during cellular hypoxia resulting from low flow
states, circulatory shock, and/or cardiopulmonary resuscitation. Research indicates hat
ischemia alters or primes cells making them more vulnerable to reperfusion injury related

to an oxygen burst of toxic reactive oxygen intermediates (ROIs) (Waxman, 1996).
Endothelial cells in particular may be directly injured by reperfusion and the

inflammation process which follows. Such injury includes damage to cell membranes,
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proteins, and chromosomes resulting in an increased cell permeability and production of

procoagulant substances (Waxman, 1996). These effects are generally considered

opposite to the effects of NO production and may be due to altered production by the
damaged endothelial cell. Endothelial production of NO during normal conditions, as

occurs during laminar shear stress or pulsatile vessel flow, is thought to have
anticoagulant and antioxidant properties that are protective against reperfusion injury

(Maier & Bulger, 1996).

Endothelial cell injury has been suggested as a result of the secondary inflammatory
process more than a result of the original ischemia or reperfusion (Maier & Bulger, 1996;

Waxman, 1996). Inflammation has been shown as responsible for alterations in
coagulation, regulation of vascular tone, vascular permeability, and regulation of

leukocyte adherence (Maier & Bulger, 1996; Waxman, 1996). Reperfusion stimulates

pro-inflammatory cytokines and macrophages to simultaneously produce both superoxide
and NO (Beckman, 1996). Research has shown that superoxide rapidly reacts with NO

converting the majority of NO to form peroxynitrite (ONOO-), a toxic reactive oxygen

intermediary. In Nitric Oxide Principles and Actions, Joseph Beckman (1999) states, “For
each 10-fold increase in the concentration of nitric oxide and superoxide, the rate of
peroxynitrite formation will increase by 100-fold” (p. 40). Peroxynitrite has been
implicated in DNA alterations, cell damage, and cell death (Szabo, 1996). Research also
suggests that it is the ratio of NO to superoxide that is responsible for the production of

peroxynitrite and that enhanced production of NO may actually limit the oxidant
reactivity of peroxynitrite (Szabo, 1996). Whether or not reperfusion injury and

endothelial cell damage accounts for decreases in NO during pGz resuscitation in this
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study is questionable; however, the measurement of arterial blood gases (ABG’s) and
superoxide levels would be helpful in evaluating possible cellular hypoxia and
NO/superoxide ratios.

Another possible factor in the NO measurement inconsistencies is whether or not pGz
produced laminar or pulsatile flow and vessel stretch during the resuscitation studies.
Adams et al., studied regional blood flow and novel CPR during pGz resuscitation and

indicated that the platform motion produces pulsatile shear stress and vessel wall stretch

resulting in vasodilation (2001a; 2001b). Numerous studies have suggested that laminar

flow related shear stress plays a role in the production of NO (Inoue et al., 1996; Uematsu
et al., 1995; Zafari et al., 1999). Conversely, research suggests that oscillatory shear

stress may reduce the steady-state level of NO and is implicated in the development of
atherosclerosis in areas of turbulent flow (Zafari et al., 1999).
Laminar flow is defined as flow that is streamlined and smooth, moving in layers or

lamina, in areas of high viscosity (Davis, Parbrook, & Kenny, 2001). Viscosity is
associated with shearing forces, the amount and type of which has importance in cell

orientation and blood vessel integrity (Davis et al., 2001; Traub & Beck, 1998.) Laminar

and pulsatile flow occur in linear areas and produce a positive shear stress that is
associated with the beat-to-beat changes of the cardiac cycle (Traub & Beck, 1998).

Research suggests that while the laminar flow produced during various research studies
may yield similar effects as the physiologic beat-to-beat positive shear stress or pulsatile
flow, the flow produced during experimentation is a steady shear stress and may have

quantitative and qualitative differences related to cell orientation (Traub & Beck, 1998).
However, research suggests that the flow produced by the pGz motion platform more
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closely mirrors the cardiac related beat-to-beat pulsatile flow than other experimental

modalities (Adams et al., 2001a, 2001b). In areas of blood vessels that have curvature or

angling, turbulent flow is produced with periods of flow reversal or oscillation (Traub &
Beck, 1998). This oscillatory flow is associated with the fatty streaks and plaque that
produce atherosclerosis and numerous other pathologic conditions (Traub & Beck, 1998).

The production of NO has been suggested as the primary factor responsible for the

athero-protective mechanisms of laminar and pulsatile positive shear stress (Traub &
Beck, 1998).
Hypothesis 2 postulated that there would be a difference between NO levels during

standard CPR and baseline levels prior standard CPR. This hypothesis was not supported.

Significance was found in decreased NO levels at 10 minutes and between 10 and 20
minutes using reductase and the ISO-NO Analyzer. Once again, these inconsistencies are
probably related to the measurement tools, use of serum versus cell culture sample, and
possible reperfusion effects on endothelial cells as explained above. Interestingly, when

the Greiss method was used to measure NO levels during standard CPR, NO levels were

significantly increased at 10 minutes. Standard CPR was performed using the Thumper
resuscitation tool, which vigorously applied 100 compressions per minute to the pig’s

chest wall. On autopsy, it was noted that all six pigs, resuscitated via the Thumper tool,

had fractured ribs. There is a possibility that the increase in NO, noted at 10 minutes, may
be due to cytokine inducible NO (iNOS). Cytokine inducible NO is stimulated by a wide
variety of cells, including macrophages, as may accompany the inflammatory process
associated with bone fracture (Kelley et al., 1996). It may be helpful to note animal
pathology related to NO results in future studies.
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Hypothesis 3 postulated that the NO levels would be greater during pGz resuscitation

than during standard CPR. This hypothesis was also not supported. Comparing pGz to
standard CPR using the Greiss method indicated that NO levels were significantly higher

than pGz levels at 10 minutes. Once again, these results are most likely due to the various

possible problems with the measurement tools. Additionally, there is a possibility that the

increase in NO during CPR is related to an increase in iNOS associated with the animal’s
pathological rib fractures.

Recent research has suggested that the action of certain anesthetic agents, on the
production or inhibition of NO pathways, may account for the variability of results found

in numerous research studies evaluating the properties of NO. Galley et al., (2001) found
that ketamine and xenon anesthesia increased cGMP in the brain and spinal cord. The
formation of cGMP is the primary route in which NO acts as an intracellular messenger

in neural pathways (Galley et al., 2001). Conversely, diazepam and pentobarbital had no
effect on cGMP in the same study (Galley et al., 2001). Whether or not ketamine played a
role in the inconsistency of the current study’s results is impossible to determine;

however, ketamine was used as a sedative and anesthetic agent in all 12 animals. It may
be beneficial to use a neutral agent such as pentobarb in future studies.

Conclusion

In conclusion, NO was significantly increased at 10 minutes during standard CPR and
using the Greiss method of measurement. Decreases in NO were found during pGz under
Greiss assay at both 10 and 20 minutes. The increase in NO was greater at 10 minutes

during standard CPR than during pGz. Although some changes in NO levels were
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significant, none of the hypotheses were supported. It is unclear from this study whether
or not pGz resuscitation has an effect on the production of NO.
The inconsistencies in the serum NO level results indicate possible problems with

both the use of serum as a sampling modality and the reduction methods utilized in
measurement via both the ISO-NO Analyzer and the Greiss assay tools. Other possible

factors associated with the inconsistent results may be unknown animal pathology,
unknown effects of anesthetic agents, and unknown flow produced during resuscitation.

The nature of NO in itself, with such a short half-life, is also problematic.

Limitations
The design of this study used an experimental repeated measures format to determine

the possibility of increased NO levels in anesthetized pigs during pGz and standard CPR.

Animal preparation, maintenance, stimulation of ventricular fibrillation, and motion

platform variables utilized the protocol employed in previous pGz studies. Serum was
drawn from an arterial line at 10-minute intervals, frozen, and samples prepared and

measured via the ISO-NO Analyzer and Greiss reaction method at a later date. Serum

samples were kept frozen in an -80° freezer until the time of use. Serum specimens
required preparation via a reduction method described previously which recommended
the use of room temperature serum. A limitation of this study is that the temperature of
the thawed samples was not ascertained prior to sample preparation. As stated previously,

alterations in variables such as temperature can interfere with the reduction of nitrate to
nitrite and hence accurate measurements.
Prior to the induction of the pGz platform motion, animals were paralyzed, intubated,
and the femoral artery cannulated for blood draws. Although, the animals were
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maintained with only 100% CPAP during pGz, they were placed on mechanical
ventilation prior to the onset of ventricular fibrillation. During the rest period before the

pGz platform motion was initiated, arterial blood gases were drawn at 5-minute intervals
and adjustments made to the ventilator parameters. A limitation of this study is that no

record was kept regarding these ventilator changes, nor were the arterial blood gases
included in this study. The lack of recorded ventilatory changes and associated arterial

blood gases may have impacted the knowledge of animal status prior to experimentation.
Additionally, autopsy of the animals post Thumper resuscitation revealed that all six

of the study animals had fractured ribs. The fact that autopsy results were not recorded on
any of the animals under study is another possible limitation of this study.
Generalization of the study findings is not possible because the study used only male

pigs as study specimens. It is not known whether a difference exists in the production of
NO between male and female pigs. Therefore, this is a limitation of the study. Although
swine are known to have a similar cardiovascular system to humans, it is also not

possible to generalize study findings as representative of human populations and this is

another limitation of the study.
The greatest limitation of this study is associated with the small sample size (n=12).
Although, this sample size was appropriate in a pilot study for feasibility, results were

inconsistent. Small sample sizes result in abnormal distributions of measurement
numbers, which makes it necessary to use non-parametric statistics for analysis.

Parametric statistical methods are generally deemed appropriate for analyzing true
experimental results as they have rigid requirements, one of which is a larger sample size.
However, as a rule of thumb in research is to obtain data from as large a sample as is
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practical and at a feasible cost, the sample size used in this study was appropriate (Polit &
Hungler, 1995). Unfortunately, the small sample size increases the probability of
inconsistent results and errors in measurement.

The results inferred from this study must be seen as groundwork for feasibility of

future studies on the production of NO during pGz resuscitation. Measurements of NO
were taken from serum samples of unknown temperature and as such may not be

accurate. Generalization of study findings is not possible due to the use of only male

animals, nor is generalization between animal and human populations possible although

they share a similar cardiovascular anatomy. Ventilator assisted respiratory parameters
were adjusted prior to the onset of pGz, based on arterial blood gases, but these were not

recorded. Autopsy results on the animals post-experimentation were also not recorded
and may have impacted the study. The smallness of sample size skewed the distribution

abnormally and necessitated the use of non-parametric statistical analysis, which may not
be appropriate for analysis of the study experiments. Although, numerous limitations and

inconsistencies exist in this study, the ability to obtain measurement values for a short
biological mediator such as NO, is extremely encouraging.
Recommendations for Future Research

This study revealed issues and weaknesses in certain areas, which may be corrected in
future studies. A fundamental question arising from the study is to find a better method of
reducing nitrate to nitrite for measurement. Repeating the study utilizing the method

outlined by Adams et al., (2001b), as described previously, might ensure more accurate

results using the Greiss assay method. Ascertaining consistent room temperature
specimens, with associated and appropriate pH, may ensure greater accuracy in the
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reduction preparation of the serum samples for measurement. The use of cell culture

confluent rather than serum, for measurement of NO via the ISO-NO analyzer, may also

yield more accurate results.
Repeating the study with a larger sample size, and a mixture of male and female
animals, is probably the most important change to make in the study design and would

possibly produce more normally distributed data and increase the ability to generalize
study results. The larger sample size would also allow the use of parametric statistical

analysis possibly providing greater accuracy and consistency in results.
Another recommendation for future studies is to use a different standard CPR

technique than the Thumper to compare NO levels between pGz and standard

resuscitation. Although the Thumper provided consistent and vigorous chest
compressions, its effectiveness was negated by the concomitant production of rib
fractures in all the animals under study utilizing that form of standard CPR. Numerous

other modalities are available such as: vest CPR, active compression-decompression
(ACD) CPR, an inspiratory impedence threshold valve, and phased thoracic-abdominal

compression and decompression (PTACD) (Lurie, 1997) An additional alternative to

these resuscitation techniques is manual CPR performed by the investigators; however,

the use of manual CPR has produced variability related to the effectiveness of chest

compressions between performers (Pinchak et al., 1988).
Future studies would benefit from recording all arterial blood gases, and ventilator

changes, both before and after the induction of resuscitation. Knowledge of these values
might reveal pathological conditions in the study animals. The measurement of
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superoxide and the superoxide to NO ratio might unveil the presence of reperfusion

injury and subsequent endothelial damage, which could alter the production of NO.

Repeating the study with the addition of calcium and potassium levels during pGz
resuscitation might also be beneficial. All three isoforms of NOS, and therefore the

synthesis of NO, are dependent on the binding of calmodulin, an intracellular protein that

binds with calcium to stimulate various biological responses (Kelley et al., 1996). In
addition, research has indicated that increased potassium and decreased ionized calcium

occur during prolonged CPR and may be responsible for failure of resuscitation efforts
(Neiman & Cairns, 1999). As such, alterations in these electrolytes could influence the
production of NO. The use of a different anesthetic agent than ketamine may decrease the
possibility of interference in the NO pathway, altering the production of NO, which has
been suggested with ketamine use (Galley et al., 2001).

Several research studies have indicated evidence of a relationship between the NO
pathway and pain nociception and antinociception (Fukada et al., 1999; Lauretti et al.,

1999). It has been postulated that NO may play opposing roles in areas such as

peripheral, spinal, and supraspinal pain sites. While NO is thought to enhance pain
perception in the periphery, NO appears to inhibit pain perception in the descending
spinal pathway and may even act directly on mu opiod receptors enhancement (Lauretti,
1999; 2000). Synergistic effects have been elicited by combining the NO pathway

derivative nitroglycerine, via transdermal patch, with intrathecal neostigmine, sufentanil
and both intrathecal and intravenous morphine for post-operative pain control. This

synergistic effect has delayed the need for post-op rescue pain medication up to 14 hours
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(Laurettti et al., 1999; 2000). Future research exploring the synergistic use of induced NO
production and analgesia in chronic pain control might also be advantageous.

Clinical Implications
Although this study did not support evidence of an increase in NO during pGz, several

studies exist that describe the vasodilatory properties of pGz resuscitation and point to a
vasoactive mediator such as NO (Adams et al., 2000a; 2000b; 2001a; 2001b).
Additionally, elevated NO levels during pGz resuscitation were obtained by Adams et al.,

during regional blood flow studies (2001b). In spite of the existence of several limitations

in this study and the obvious need for repeating the experiments, the possibility of

enhanced NO production during pGz remains likely. Previous studies utilizing pGz
resuscitation have shown that pGz both ventilates the lungs, and perfuses the organs,

providing and maintaining oxygenation and circulation which is the goal of CPR (Adams
et al., 2000a; 2000b; 2001a; 2001b). Adequate circulation and ventilation has been
maintained in animals under study in cardiac arrest for 20 minutes with pGz platform

movement. These animals were successfully resuscitated, found to have insignificant
reperfusion injuries, and little changes in ABG’s (Adams et al., 2001a, 2001b). As such,
pGz appears to possess clinical usefulness as a modality in situations of prolonged

cardiac resuscitation and possibly the ability to increase survival rates in humans.

Evidence indicates that standard CPR provides only 15-20% of the normal cardiac
perfusion and 25-30% of cerebral perfusion (Lurie, 1997). Not only does pGz provide

excellent regional blood flow to the heart and brain during cardiac arrest, it also provides
almost 50% of flow to the intestinal mucosa via the sphlanchnic artery, were occlusion is

responsible for much of the ischemic sequelae and subsequent mortality after standard
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resuscitation (Adams 2001b). The ability of pGz to provide increased blood flow is
related to vasodilation of the vasculature, which allows driving forces of the platform
motion to perfuse target organs. Once again, this vasodilation is thought related to the

enhanced production of NO and the associated decreased vascular resistance. The ability
to produce increased perfusion to the brain, heart, and other organs, under low-pressure

situations, may be clinically significant in human populations experiencing any low flow
related pathology. Therefore, pGz and increased production of NO, may be clinically

helpful as a treatment modality in decreasing the development of artherosclerosis,
preventing cardiovascular changes associated with diabetes, preventing re-stenosis of

cardiac vessels post surgical innovation, maintaining circulation in quadraplegic or
paraplegic patients, and providing improved circulation during multiple organ failure,

congestive heart failure, and sepsis. Additionally, the enhanced production of NO during
pGz motion may be of clinical value in maintaining cadaveric or non-beating heart organ
donors or brain dead donors for organ transplantation. With the ever-increasing shortage

of organs for transplantation, particularly those from living donors, the ability to maintain

perfusion and decrease ischemic damage to these organs may also have clinical
significance.

60

List of References

Achleitner, U., Wenzel, V., Strohmenger, H. U., Krismer, A. C., Lurie, K. G., Lindner, K
H., et al. (2000). The effects of repeated doses of vasopressin or epinephrine
on ventricular fibrillation in a porcine model of prolonged cardiopulmonary
resuscitation. Anesthesia and Analgesia, 90, 1067-1075.
Adams, M. L. & Cicero, T. J. (1998). Alcohol intoxication and withdrawal: the role of
nitric oxide. Alcohol, 16 (2), 153-158.
Adams, J. A., Mangino, M. J., Bassuk, J., Inman, D. M., & Sackner, M. A. (2000a).
Noninvasive motion ventilation (NIMV): A novel approach to ventilatory support.
Journal of Applied Physiology, 89, 2438-2446.
Adams, J. A., Mangino, M. J., Bassuk, J., & Sackner, M. A. (2000b). Hemodynamic
effects of periodic Gz acceleration in meconium aspiration in pigs. Journal of
Applied Physiology, 89, 2447-2452.

Adams, J. A., Mangino, M. J., Bassuk, J., Kurlansky, P., & Sackner, M. A. (2001a).
Novel CPR with Periodic Gz Acceleration. Journal of Applied Physiology
Adams, J. A., Mangino, M. J., Bassuk, J., Kurlansky, P., & Sackner, M. A. (2001b).
Regional blood flow during periodic acceleration. Critical Care Medicine, 29 (10)
1983-1987.

American Heart Association (AHA). (1997). Advanced Cardiac Life Support. Dallas, TX:
Author.
American Nurse Association (ANA). (1991). Standards of clinical nursing practice.
Washington, DC: Author.
Beckman, J. S. (1996). The physiological and pathological chemistry of nitric oxide. In J.
Lancaster (ed.). Nitric oxide: Principles and actions. San Diego, CA: Academic Press.

Bellamy, R., Safar, P., Tisherman, S. A., Basford, R., Bruttig, S. P., Capone, A., et al.
(1996). Suspended animation for delayed resuscitation. Critical Care Medicine, 24
(Suppl. 2), S24-S46.
Berg, R. A., Hilwig, R. W., Kern, K. B., & Ewy, G. A. (2000). “Bystander” chest
compressions and assisted ventilation independently improve outcome from piglet
asphyxial pulseless “cardiac arrest”. Circulation, 101, 1743-1748.

Berkels, R., Purol-Schnabel, S., & Roesen, R. (2001). A new method to measure
nitrate/nitrite with a NO-sensitive electrode. Journal of Applied Physiology, 90, 317320.

61

Burden, N. & Saulf, N. (2001). Perianesthesia standards for ethical practice. Journal of
PeriAnesthesia Nursing, 16 (1), 2-5.
Burns, N. & Grove, S. K. (1993). The practice of nursing research: conduct, critique, &
utilization (2nd ed.). Philadelphia: Saunders.
Busse, R., Mulsch, A., Fleming, I., & Hecker, M. (1993). Mechanisms of nitric oxide
release from the vascular endothelium. Circulation, 87 (suppl. V), V18-V25.

Ceccarelli, P., Bigatello, L. M., Hess, D., Kwo, J., Melndez, L., & Hurford, W. E.
(2000). Inhaled nitric oxide delivery by anesthesia machines. Anesthesia and
Analgesia, 90 (2), 482-488.
Christopherson, K. S. & Bredt, D. S. (1997). Nitric Oxide in excitable tissue:
Physiological roles and disease. Journal of Clinical Investigation, 100 (10). 24242429.

Davis, P. D., Parbrook, G. D., & Kenny, G. N. C. (2001). Basic physics and measurement
in anesthesia (4th ed.). Woodburn, MA: Butterworth-Heinemann.
De Keulenaer, G. W., Chappel, D. C., Ishizaka, N., Nerem, R. M., Alexander, R. W., &
Griendling, K. K. (1998). Oscillatory and steady laminar shear stress differentially
affect human endothelial redox state: Role of super-oxide producing NADH oxidase.
Circulation Research, 82, 1094-1101.
Eynon, C. A. (2000). Minimally invasive direct cardiac massage and defibrillation.
Resuscitation, 47, 325-328.
Fukuda, T., Saito, S., Saito, S., Harukuni, I., & Toyooka, H. (1999). Halothane minimum
alveolar concentration and neuronal nitric oxide synthase activity of the dorsal horn
and the locus ceruleus in rats. Anesthesia and Analgesia, 89. 1035-1039.

Furchgott, R. F. (1993). The discovery of endothelium-dependent relaxation. Circulation,
87 (Suppl. V), V3-V8.
Furchgott, R. F. (1999). Discovery of endothelium-derived relaxing factor and its
identification as nitric oxide. In J. A. Panza & R. O. Cannon (Eds.). Endothelium,
nitric oxide, and atherosclerosis: From basic mechanisms to clinical implications.
Armonk, NY : Futura.

Galley, H. F., Cras, A. E., Logan, S. D., & Webster, N. R. (2001). Differential nitric
oxide synthase activity, cofactor availability and cGMP accumulation in the central
nervous system during anesthesia. British Journal of Anaesthesia, 86 (3), 388-394.

62

Gronert, G. A. (2001). Cardiac arrest after succinylcholine; Mortality greater with
rhabdomyolysis than receptor upregulation. Anesthesiology, 94 (3), 523-529.

Guyton, A. C. & Hall, J. E. (2000). Textbook of medical physiology (10th ed.).
Philadelphia: W. B. Saunders.

Harrison, D. G. (1997). Perspective series: Nitric oxide and nitric oxide synthases.
Journal of Clinical Investigation, 100 (9), 2153-2157.
Heavner, J. E., Shi, B., & Pitkanen, M. (1999). Nitric oxide synthesis inhibition
Modifies the cardiotoxicity of tetracaine and lidocaine. Anesthesia and Analgesia,
88 (4), 717-722.
Idris, A. H., Becker, L. B., Ornato, J. P., Hedges, J. R., Bircher, N. G., Chandra, N. C.,
et al. (1996). Utstein-style guidelines for uniform reporting of laboratory CPR
research: A statement for health care professionals from a task force of the American
Heart Association, the American College of Emergency Physicians, the American
College of Cardiology, the European Resuscitation Council, the Heart and Stroke
Foundation of Canada, the Institute of Critical Care Medicine, the Safar Center for
Resuscitation Research, and the Society for Academic Emergency Medicine. Annals
of Emergency Medicine, 28 (5), 527-541.
Idris, A. H., Wenzel, V., Becker, L. B., Banner, M. J., & Orban, D. J. (1995). Does
hypoxia or hypercarbia independently affect resuscitation from cardiac arrest? Chest,
108, 522-527.
Inoue, N., Ramasamy, S., Fukai, T., Nerem, R. M., & Harrison, D. G. (1996). Shear
stress modulates expression of Cu/Zn Superoxide dismutase in human aortic
endothelial cells. Circulation Research, 79 (1), 32-36.

Jawan, B., Cheung, H. K., Chong, Z. K., Poon, Y. Y., Cheng, Y. F., Chen, H. S.,
et al. (2000). Aspiration in transtracheal oxygen insufflation with different insufflation
flow rates during cardiopulmonary resuscitation in dogs. Anesthesia and Analgesia,
91, 1431-1435.
Kelly, R. A., Baligand, J., & Smith, T. W. (1996). Nitric oxide and cardiac function.
Circulation Research, 79, 362-380.
Karkela, J., Pasanen, M., Kaukinen, S., Morsky, P., & Harmoinen, A. (1992). Evaluation
of hypoxic brain injury with spinal fluid enzymes, lactate, and pyruvate. Critical Care
Medicine, 20 (3), 378-385.
Krismer, A. C., Linder, K. H., Wenzel, V., Mayr, V. D., Voelckel, W. G., Lurie, K. G.,
et al. (2001). The effects of endogenous and exogenous vasopressin during

63

experimental cardiopulmonary resuscitation. Anesthesia and Analgesia, 92,
1499-1504.

Larach, M. G., Gronerts, G. A., Rosenberg, H., & Allen, G. C. (1997). Hyperkalemic
cardiac arrest during anesthesia in infants and children with occult myopathies.
Clinical Pediatrics. 9-15.

Lauretti, G. R., Oliveira, A. P., Juliao, M. C., Reis, M.P., & Pereira, N. L. (2000).
Transdermal nitroglycerine enhances spinal neostigmine postoperative analgesia
following gynecological surgery. Anesthesiology, 93 (4), 943-946.

Lauretti, G. R., de Oliveiria, R., Reis, M. P., Mattos, A. L., & Pereira, N. L. (1999).
Transdermal nitroglycerine enhances spinal sufentanil postoperative analgesia
Following orthopedic surgery. Anesthesiology, 90 (3), 734-739.

Loeb, A., Raj, N. R., & Longnecker, D. E. (1998). Cerebellar nitric oxide is increased
during isoflurane anesthesia compared to halothane anesthesia: a microdialysis study
in rats. Anesthesiology, 89 (3), 723-730.
Liao, J. K. (1999). In J. A. Panza & R. O. Cannon (Eds.). Endothelium, nitric oxide, and
atherosclerosis: From basic mechanisms to clinical implications. Armonk, NY:
Futura.

Lurie, K. G. (1997). Recent advances in mechanical methods of cardiopulmonary
resuscitation. Acta anaesthesiologica Scandinavica, (Supp), 49-52.
Luscher, T. E., Boulanger, C. M., Zhihong, Y., Noll, G., & Yasuki, D. (1993).
Interactions between endothelium-derived relaxing and contracting factors in health
and cardiovascular disease. Circulation, 87 (Suppl. V), V36-V44.

Maier, R. V. & Bulger, E. I. (1996). Endothelial changes after shock and injury. New
Horizons, 4 (2). 211-223.

Mancini, M. E., & Kaye, W. (1999). AEDS: Changing the way you respond to cardiac
arrest. AJN, 99 (5), 26-30.
Miller, V. M., Aarhus, L. L., & Vanhoutte, P. M (1986). Modulation of endothelium
dependent responses by chronic alterations of blood flow. American Journal of
Physiology, 251 (Heart Circ. Physiol. 20), H520-H527.
Morgan, G. E., Mikhail, M. S., & Murray, M. J. (2002). Clinical Anesthesiology (3rd ed.).
New York: McGraw Hill.

Mossad, E. B. (2001). Pro: Intraoperative use of nitric oxide for treatment of pulmonary

64

hypertension in patients with congenital heart disease is effective. Journal of
Cardiothoracic and Vascular Anesthesia, 15 (2), 259-262.
Mugge, A., Elwell, J. H., Peterson, T. E., & Harrison, D. G. (1991). Release of intact
endothelium-derived relaxing factor depends on endothelial superoxide dismutase
activity. American Journal of Physiology, 260 (Cell Physiol. 29), C219-C225.

Munro, B. H. (2001). Statistical methods for health care research (4th ed.). Philadelphia:
Lippincott.
Niemann, J. T.& Cairns, C. B. (1999). Hyperkalemia and ionized hypocalcemia during
cardiac arrest and resuscitation: Possible culprits for postcountershock arrhythmias?
Annals of Emergency Medicine, 34 (1), 1-7.
Paiva, E. F., Kern, K. B., Hilwig, R. W., Scalabrini, A., & Ewy, G. A. (2000). Minimally
invasive direct cardiac massage versus closed-chest cardiopulmonary resuscitation in a
porcine model of prolonged ventricular fibrillation cardiac arrest. Resuscitation, 47,
287-299.
Palmer, R. M. J., Ferrige, A. G., & Moncada, S. (1987). Nitric oxide release accounts for
the biological activity of endothelium-derived relaxing factor. Nature, 327, 523-526.

Panza, J. A. & Cannon, R. O. (Eds.). (1999). Endothelium, nitric oxide, and
atherosclerosis: From basic mechanisms to clinical implications. Armonk, NY:
Futura.
Pinchak, A. C., Hancock, D. E., Hagen, J. F., & Hall, F. B. (1988). Chest wall
acceleration and force measurements in simulated manual and mechanical
cardiopulmonary resuscitation. Critical Care Medicine, 16 (2), 151-160.

Polit, D. E. & Hungler, B. P. (1999). Nursing research: Principles and methods (6th ed.).
Philadelphia: Lippincott.
Reid, K. H., Mullins, E. R., & Iyer, V. G. (1998). Changes in brainstem auditory evoked
response latency predict survival after CPR in a rat model of cardiac arrest and
resuscitation. Resuscitation, 36, 65-60.
Roig, E., Melis, M. M., Heras, M., Rigol, F., Epelde, G., DeCandia, g., & Sanz, G.
(2000). Nitric oxide inhibition intensifies the depressant effect of cocaine on the left
ventricular function in anesthetized pigs. European Journal of Clinical Investigation,
30, 957-963.

Schleien, C. L., Kuluz, J. W., & Gelman, B. (1998). Hemodynamic effects of nitric oxide
synthase inhibition before and after cardiac arrest in infant piglets. American Journal
of Physiology, 274, H1378-H1385.

65

Schwenzer, K. J., Smith, W. T., & Durbin, C. G. (1993). Selective application of
cardiopulmonary resuscitation improves survival rates. Anesthesia and Analgesia, 76,
478-484.

Szabo, C. (1996). The pathophysiological role of peroxynitrite in shock, inflammation,
and ischemia-reperfusion injury. Shock, 6 (2), 79-88.

Tonner, P. H., Scholz, J., Schlamp, N., & Schulte am Esch, J. (1999). Inhibition of
Nitric oxide metabolism enhances the hypnotic-anesthetic action of the a2Adrenoceptor agonist dexmedetmidine in vivo. Journal of Neurosurgical
Anesthesiology, 77 (1), 37-41.

Traub, O. & Beck, B. C. (1998). Laminar shear stress: mechanisms by which endothelial
cells transduce an atheroprotective force. Arteriosclerotic Thrombotic Vascular
Biology, 18. 677-685.
Tsuchida, H., Tanaka, S., Seki, S., Inoue, H., & Namiki, A. (1999). Halothane attenuates
Nitroglycerine-induced vasodilation and a decrease in intracellular Ca2+ in the rat
thoracic aorta. Anesthesia and Analgesia, 89 (1), 49-54.

Uematsu, M., Ohara, Y., Navas, J. P., Nishida, K., Murphy, T. J., Alexander, R. W.,
et al. (1995). Regulation of endothelial cell nitric oxide synthase mRNA expression by
shear stress. American Journal of Physiology, 269 (Cell Physiol. 38), C1371-C1378.
Vanhoutte, P. M. (1993). Other endothelium-derived vasoactive factors. Circulation, 87
(Suppl.V), V9-V17.

Voelckel, W. G., Lurie, K. G., Zielinski, T., McKnite, S., Plaisance, P., Wenzel, V.,
et al. (2001). The effect of positive end-expiratory pressure during active
compression decompression cardiopulmonary resuscitation with the inspiratory
threshold valve. Anesthesia and Analgesia, 92, 967-974.

Waxman, K. (1996). Shock: ischemia, reperfusion, and inflammation. New Horizon, 4
(2), 153-160.

Woda, R. P., Dzwonczyk, P. E., Bernacki, B. L., Cannon, M., & Lynn, L. (1999). The
ventilatory effects of auto-positive end-expiratory pressure development during
cardiopulmonary resuscitation. Critical Care Medicine, 27 (10), 2212-2217.
World Precision Instruments, Inc. (WPI). (2000). ISO-NO Mark II: Isolated
nitric oxide meter and sensors instruction manual. Retrieved August 3, 2001, from the
WPI Web site: http://www.wpiinc.com.

66

Zafari, A. M., Harrison, D. A., & Griendling, K. K. (1999). Vascular oxidant stress and
nitric oxide bioactivity. In J. A. Panza & R. O. Cannon (Eds): Endothelium, nitric
oxide, and atherosclerosis. Armonk, NY: Futura.

Ziglar, M. K. (2000). Application of base deficit in resuscitation of trauma patients.
International Journal of Trauma Nursing, 6, 81-84.

67

APPENDIX
IACUC APPLICATION AND APPROVAL

68

FLORIDA INTERNATIONAL UNIVERSITY
INSTITUTIONAL ANIMAL CARE AND USE COMMITTEE (IACUC)

ANIMAL CARE AND USE FORM
IACUC Approval #_______________
I.

GENERAL INFORMATION

A. Project
Title:

EFFECTS OF PERIODIC ACCELERATION (pGz) ON NITRIC OXIDE DURING
RESUSCITATION IN ANESTHETIZED PIGS

B. Principal
Investigator:

Ingrid Gunnlaugsson, BSN, RN
SS#:
_________________________________________

□ Faculty

Position
:

Graduate
Student**

□ Undergraduate
*
Student

KI

Animal Care Training/Certification:

Department / Campus
Address:

Zip

Fax

Email
Address:

#:

___________________

C. Co-Investigators
Charlotte A. Richmond, PhD, RN

Facult
y

Grad

Undergra
d

El

□

□

□

Jose A. Adams, MD

□

Jorge Bussak, MD

□

Dongmei Wu, MD, OhD

06- 06-2001

John P. McDonough, CRNA, Ed.D., ARNP
_____________________________

Nursing/ ACH 240C

Phone
#:

Yes, please indicate date

□
No

*FACULTY SUPERVISOR (if PI is a
student):

KJother
(specify):

□

Othe
r

Animal Care
Training/Certification?
If yes indicate date

□ □

No

□

E □

□

□

El □

□

□

El □

No
No
No

El

1996

E

2001

E

2002

E

2002

Yes
Yes

Yes
Yes

II. PROJECT INFORMATION
A. Status Of Project Review:
K New
Project

Source Of
Funding:

□ New
Teaching

□ Revision of previously approved
Project

□ Continuation of approved
project

KI Not Seeking
_____ Funding

Miami Heart Institute

69

Start Date:
B.

2001

2003

Project Summary: In the space below, summarize in lay terms the objectives, animals used and
major procedures of the project.

In an ongoing study at the Harry Pearlman Research Institute at Mt. Sinai, intraoperative resuscitation
on anesthetized pigs, using a pGz approach (motion platform), is under investigation. Resuscitation via
pGz motion is implemented by moving the anesthetized and arrested animal in a headword-tofootward direction using a platform device. By manipulating the platform’s speed and frequency,
acceleration forces ventilate the pig’s lungs and stimulate cardiovascular function. The pGz platform’s
movement also produces vasoactive modulators such as hemodynamic shear stress and pulsatile vessel
stretch that may increase the production of endogenous NO. As such, an increase in endogenous NO is
expected with pGz motion resuscitation. Whether an increase in NO actually occurs with pGz and
whether such an increase is beneficial, is not known. To date, little research exists on the possible
physiological responses to pGz. Furthermore, there is a possibility that with continued research, pGz
resuscitation may become applicable to humans in the future as an alternate to standard CPR.
The study will address the following problem in Yorkshire pigs: To what extent does periodic
acceleration (pGz) motion affect the physiological response of nitric oxide (NO) during intraoperative
resuscitation in anesthetized pigs? The purpose of this study is to compare the physiological responses
during pGz resuscitation to standard cardiopulmonary resuscitation in anesthetized and arrested pigs.
Two groups of randomly selected male juvenile Yorkshire pigs (n=6 each) weighing (9.5+1.2 kg) will
be studied in an experimental repeated measures design. In order to test the study hypothesis, two
experiments will be performed: (1) measurement of NO production during pGz resuscitation, and (2)
measurement of NO production during standard CPR resuscitation. Comparisons will be made between
the two levels. Nitric Oxide levels will be measured at baseline and at 10-minute intervals (X 3) during
resuscitation. In order to monitor the animal’s cardiovascular function, heart rate (HR) and arterial
pressure will be measured via electrocardiogram and cannulation of the femoral artery, respectively.
The arterial line will also allow for procurement of blood gases and blood specimen draws. The
animals will also undergo endotracheal intubation and will receive 100% 02 with 5 cmHg CPAP in
order to reduce hypoxic consequences. Additionally, a right venous catheter will be placed in the
internal jugular vein and used for administering fluids and medications and measuring right atrial
pressure. All invasive catheters will be sized according to animal anatomical requirements. A bipolar
fibrillating wire will be placed subcutaneously, across the apex of the heart, and used to induce
ventricular fibrillation in the study animal via delivery of 30 volts of A.C. current at 60 Hz. The
animals will be placed on the motion platform with extremities bound in order to maintain a close
approximation with the platform device. The platform will move in a cephalic head to foot direction
with periodic accelerations and decelerations. This motion will allow for manipulation of the speed and
frequency of oscillations. The frequency of acceleration and deceleration movements range from O.510 Hz at a force of 0.1-1.5 G. Approximation of beats per minute (bpm) to corresponding frequency of
motion is 1 Hz = 60 bpm.
III. PROCEDURE CHECKLIST:
Affirmative answer
requires completion
of:

A. Tissue only?

□Yes
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B. Live vertebrates involved?
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□No
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D. Ascites production and harvesting?
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Section VII

E. Drug administration(other than anesthetics or analgesics)
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□No
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1. Terminal?

□Yes

□No

Section VI

2. Survival?

□Yes

□No
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3. Multiple survival?
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radioactive or carcinogenic agents)
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□No

Section
X(A)

2. Restraint of animal's freedom of movement?
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Section
X(B)

3. Special diets, fasting or housing conditions

□Yes

□No

Section
X(C)

4. Pain or distress experienced by subjects

□Yes

□No

Section
X(D)

5. Production of blindness or paralysis

□Yes

□No

Section
X(D)

6. Death as an endpoint in any procedure

□Yes

□No

Section X(E)

7. Will animals be fasted

□Yes

□No

Section X(F)

8. Special assistance from facility staff

□Yes

□No

Section
X(G)

9. Special circumstances requiring additional documentation

□Yes

□No

Section
X(H)

F. Surgical procedure?

G. Special circumstances:

IV. ANIMALS
A. What species and how many animals/species will be used?
Yorkshire pigs. In total we propose the use of 12 pigs. Due to arrythmia and other possible
complications, we expect to utilize a total of 16 animals.
B. Justify the necessity to use this (these) species. Indicate why non-animal alternatives cannot be
used by describing the methods and sources which helped you determine that alternatives are not
available.
This is a part of a feasilbilty study of non-invasive motion platform for CPR currently being conducted
at Mt. Sinai Medical Center. This project requires invasive monitoring of systemic and cerebral
hemodynamics. This animal
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model has been used extensively in CPR research and neonatal research due to its human similarities of
both cerebral and systemic hemodynamics.
C. On what do you base your assurance that this study is not unnecessarily duplicative?
This motion platform device is a new device. Other than previous work done at Mt. Sinai, there is no
prior experience using this platform for CPR studies.

D. Justify the number of animals to be used. Please note the statistical methods used in arriving at
these numbers.
The power to detect 20% change in hemodynamic parameters would require a minimum of 10 animals
per study. Data collection for this proposed protocol will be collected during the time these animals are
participating in the on-going study by Dr. Jose A. Adams (Mt. Sinai) addressing the feasibility of this
non-invasive motion platform for CPR.
E. Indicate the names and qualifications/training of the personnel having contact with the animals.
If you have a need for personnel training, please
,—
indicate
|_| es I2SJ 0
Ingrid Gunnlaugsson, BSN, RN - Graduate nursing student who has an extensive background in
monitoring critically ill patients, including pulmonary & hemodynamic measurement. She has been
trained to use the Isolated Nitric Oxide Meter and Sensors
Dr. Charlotte Richmond, Ph.D., RN - Nurse physiologist experienced in pulmonary & hemodynamic
measurement.
Jose A. Admas, MD - Experienced in surgical procedure for this animal species as well as all
pulmonary and hemodynamic measurement.
Jorge Bassuk, MD - Anesthesiologist - Experienced in surgical procedure for this animal species as
well as all pulmonary and hemodynamic measurements assessment of anesthesia.
Dongmei Wu, MD, PhD - Experienced in surgical procedure for this animal species as well as all
pulmonary and hemodynamic measurements.

F. How many animals (each species) are anticipated to be housed at any one time?
3 - 4 at the Harry Perlamn Reseach Institute at Mt. Sinai Medical Center
G. List the building and room number where project efforts will take place. Indicate the time period
animals will be outside the housing facility.
The procedures will take place in room # 249 in the Harry Pearlman Research Institute at Mt. Sinai
Medical Center.
H. Fully describe the method of euthanasia, indicating the agent, dose and route of administration and
how dead animals will be disposed of.
Concentrated Pentobarbital (Euthanol) dose of 5cc IV. The animals will be red-bagged and incinerated
per Mt. Sinai's policies & procedures.

The following items must be completed only for items marked yes on Page 2.

V. Immunization and bleeding:
A. Frequency of bleeding:
baseline and every 10 minutes X 3
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B. Volume of blood withdrawn:
0.2 - 0.3cc per draw
C. Method of collection:
Indwelling arterial catheters
D. Hybridoma or ascites:
Agents used:

Volume injected:
Site of injection:

Frequency of injection:
Frequency of fluid withdrawn:
Volume of fluid withdrawn:

Maximum number of collections:

Frequency of animal observation:

F. Incomplete Freund's adjuvant
used?

EjYes

EjNo

Number of
times?

_____

G. Name(s) and frequency of other adjuvant's used:

VI.

VII.

Administration of drugs other than anesthetic and analgesics:
Indicate the drug(s) to be utilized, the amounts(s), routes(s) of administration.

Surgical procedure:

Note: Asceptic techniques are required for all warm blooded animals. Surgery must be performed in
a surgical area approved by LACUC.

A. Describe what happens to the animal during the surgical procedure (if multiple surgeries, justify):

The animals will be anesthetized and undergo endotrAcheal intubation and will receive 100% 02 with
5 cmHg CPAP in order to reduce hypoxic consequences. Additionally, arterial and venous catheters
will be placed in the femoral artery and right atrium and used for administering fluids and medications
and measuring arterial pressure and right atrial pressure. All invasive catheters will be sized according
to animal anatomical requirements. A bipolar fibrillating wire will be placed subcutaneously, across the
apex of the heart, and used to induce ventricular fibrillation in the study animal via delivery of 30 volts
of A.C. current at 60 Hz. The animals will be placed on the motion platform with extremities bound in
order to maintain a close approximation with the platform device. The platform will move in a cephalic
head to foot direction with periodic accelerations and decelerations. This motion will allow for
manipulation of the speed and frequency of oscillations. The frequency of acceleration and deceleration
movements range from 0.5-10 Hz at a force of 0.1-1.5 G. Approximation of beats per minute (bpm) to
corresponding frequency of motion is 1 Hz = 60 bpm.

Buildin

Mt
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Room

249

B. Where will the surgery be
performed?

Sinai

_______

C. List the names and training of those who will perform the surgery.
Drs. Adams and Bussak have been performing these surgical procedures for over 5 years. Dr Wu has
been trained by Drs. Adams and Bussak and has been performing these procedures for 6 months.

D. Identify the anesthetic agent(s), dosage(s) and route(s) of administration. Describe the method
used to monitor level of anesthesia.

All anesthetic agents will be adminsitered by Dr. Bussak, who is an anesthesiologist. The preparation
of the study animals will be performed using the protocol of previous pGz experiments. Animals under
study will be anesthetized with Ketamine (lOmg. Kg, I.M.) prior to entering the research laboratory
procedure site. Additional Ketamine will be administered prior to invasive procedures and the animals
will be held in a surgical plane of anesthesia with an intravenous propofol and succinylcholine
combination. Paralysis will be induced via Pancurium Bromide at 0.1 mg/kg with continued
supplementation as needed. The depth of anesthesia will be determined by the loss of the corneal and
spinal reflex with accompanying animal heartbeat of 150 bpm as is considered normal in swine.
E. If a gas anesthetic is used, is a scavenging system in
place?

I |Yes

IXlNo

F. Will paralytic drugs be
[>3Yes dNo
used?
If yes, indicate the agent(s), dosage(s) and frequency of administration and the method of
monitoring anesthesia.
Paralysis will be induced via Pancurium Bromide at 0.1 mg/kg with continued supplementation as
needed. The depth of anesthesia will be determined by the loss of the comeal and spinal reflex with
accompanying animal heartbeat of 150 bpm as is considered normal in swine.
G. Will post-operative antibiotics be
□
IXlNo
used?
Yes
If yes, name the antibiotic and how it will be administered. If no, explain/justify.
H. What post-operative measures will be taken to minimize discomfort? If none, explain/justify.
Pigs will be humanely euthanized with concentrated Pentobarbital (Euthanol). immediately after the
study.

I.

If analgesia is used post-operatively, indicate:

Type
(name):
Dose:
Frequency and route of
administration:
J.

Name the individual(s) responsible for post-operative care and indicate where post-operative
records will be
maintained. **
Note.
A medical history chart must be maintained with no
less than daily entries.
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VIII. Special conditions:

Identify the isotope or hazardous material:

A.

1. Exposure route:
2. Exposure dose:

3. Exposure
duration:
4. Will the agent be
excreted?
If
yes

I I in
urine

I |Yes

□ in
feces

| [No

O exhaled

5. Indicate where animal(s) will be housed during and after exposure.

6. Indicate the method of disposal for the material/animal.
B. How will animal activity be restricted (as a result of surgical procedures or by chairs, tethers,
stanchions, metabolism cages, etc?)

1. Indicate duration of
restriction:

During surgery and during CPR, while anesthetized, pig will be

2.
Duration:

1-3 hours

3.
Frequency:

continuosly during anesthesia, surgey & resuscitation

4. How frequently will the animal be observed during
restraint?

continuously

C. List any special housing requirements required for the project (lighting, feed, caging, etc.).

none
D. Describe measures which will be taken to alleviate pain or distress. If no measures are taken, you
must justify this decision.

Animals will be humanely euthanized at end of resuscitation study

E. Justify why death as an endpoint is necessary to this study.

This protocol being presented is a small piece of a large project that includes adminsitration of
microspheres and microscopic examination of brain slices post resuscitation.
F.

How long and how often will a single animal be fasted.

5 hours prior to surgical procedure
G. Describe the special assistance required from the animal facility supervisor or staff,
none
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H. Indicate any procedure or occurrence which might be questioned upon review of your study and
provide additional explanation or justification that will be helpful in reviewing this procedure. If
describing behavioral conditioning, indicate the purpose of the conditioning, reinforcement techniques
and criteria used to monitor the animal's condition.
Investigators at the Harry Pearlman Institute have been using this Mt. Sinai approved protocol for over
5 years.In order to compare data collected over the last 5 years with data being collected in the current
year, no changes will be made to the present protocol This student’s protocol is a small piece of a
larger project. The required amount of blood, an additional 0.2 to 0.3cc drawn at baseline and repeated
X3, will be taken from the blood already being obtained for the main protocol.

XI. Assurance:

The policies and procedures of Florida International University and the USDA apply to all activities
involving live vertebrate animals performed by the personnel at this institution. No activities involving
the use of these animals are to be initiated without prior written approval of the FIU Institutional
Animal Care and Use Committee (IACUC).

The undersigned is familiar with and agrees to adhere to the PHS Policy on Humane Care and Use of
Laboratory Animals, the regulations and policies of the USDA, the NIH Guide to the Care and Use of
Laboratory Animals and FIU policies. I assure that any change in the care and use of animals involved
in this protocol will be promptly forwarded to the IACUC for review and approval prior to
implementation of the change. I also assure that only properly trained individuals will participate in
this project.
Animals will not be transferred between investigators without prior written approval of the IACUC.

Signature of Principal Investigator

Dai
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Florida International University

Miami's public research university
Department of Biological Sciences

To:

Ingrid Gunnlaugsson, BSN, RN
Condon, Ph.D.
Acting Chair, LACUC

FROM: Keith

Date: 2/26/02

Re:

FIU IACUC Protocol: Effects of Anesthesia and Periodic Acceleration (pGz) on
Thermoregulatory Responses During Resuscitation in Pigs

The majority of the committee has approved your protocol pending modification (see
below). However, a minority has requested a meeting with the PI and adviser to address
concerns about the statistical analysis. Since an assembling of the committee takes a
good deal of time (two members are off campus), I would like to propose that the PI
respond to the issues raised below, paying particular attention to the statistical analysis
(Section IV.D.). If the submitted modifications, including the explanation of the
statistical analysis, are acceptable to the committee, then an approval with modifications
will be issued. If the submitted modifications are unacceptable, then I will arrange a
meeting with the PI.
If this arrangement is not acceptable to you, please notify me and I’ll arrange a meeting
as soon as possible.

In regards to power analyses to determine sample sizes, the statement should include an
estimate of the differences in the parameters being measured between groups, the
statistical test(s) being employed, an effect size and an alpha level.

On the following pages are a synopsis of the points that must be addressed in the
modification

If I can assist you in the re-submission, please don’t hesitate to contact me at x2604 or by
e-mail at condon@fiu.edu.
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II. B.

Please define (not just describe) pGz; that is, to what does each of these letters
refer?
How long will the animals be in fibrillation and/or subject to resuscitations? You
are monitoring every 10 minutes suggesting a rather prolonged period. How long
will the resuscitations last?

Also, please confirm in this section that the animals will be euthanized at the end
of the experiment surgery without regaining consciousness.
Curare wipes out muscle tone - does this affect blood pressure or other
physiological variables that would in turn affect NO production?
III. G.3.Should be yes; complete section X(C)
This is, since the animals are not being house at FIU, please describe the housing
conditions at the study site.

III. G.4.Should be yes; complete section X(D)

IV. A. The species is Sus scrofa.
Please describe more fully “other possible complications” which may require the
use of additional animals
IV.D. Is the 10 animals “per study” suggested by your analysis the number of animals
total or the number of animals in each of your two groups. If the latter, then your
effective sample size is likely too small (N = 12) to detect a significant difference.
Explain.
The section on statistical power made no sense [to me.] What statistical tests are
used to detect changes in NO level within subjects and to compare groups? What
is the predicted variance in NO levels across comparison groups. What is the
alpha level?

VII.B. The methods of standard CPR resuscitation that will be used for one of the groups
are not described.
VII.H. Again, please clarify if the pigs are euthanized at the end of the surgery without
gaining consciousness.
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To: The Department of Biological Sciences
Attention: Keith Condon, Ph.D. and FIU IACUC Committee

From: Ingrid Gunnlaugsson, BSN, RN, CCRN and Principle Investigator
Date 3/17/02
Re: FIU IACUC Protocol: Effects of Periodic Acceleration (pGz) on Nitric Oxide During
Resuscitation in Anesthetized pigs.

The following statements are in response to the letter from Dr. Condon dated 2/26/02 and
hope to clarify any questions regarding the protocol used during pGz and Nitric Oxide
(NO) experiments.
Clarification of Specific Questions

11B. Please define (not just describe) pGz; that is, to what does each of these letters
refer?
Periodic Gz acceleration (pGz) refers to a novel cardiopulmonary resuscitation method
(periodic Gz acceleration) and is the application of head to foot oscillations, which occur
on a motion platform device, and cause periodic sinusoidal inertial forces (G’s) in the
spinal axis of anesthetized pigs. The motion platform device moves in a cephalic head to
foot direction with periodic acceleration and deceleration. The speed and frequency of the
pGz motion can be manipulated. The frequency and force of pGz platform movements
are used as control with frequency set at 2 HZ with 1 HZ equaling approximately 60 heat
beats per minute. The inertial force is set at 0.6 G’s for all experiments. Movements of
the platform both ventilate and stimulate cardiovascular circulation in anesthetized and
arrested pigs. Ventilations occur via the force of acceleration movement, which thrusts
the animal’s abdominal contents toward the diaphragm, producing negative pleural
pressure respiration similar to human breathing.

The protocol in use for the NO experiments is the same protocol used for previous pGz
experiments by Dr. Tony Adams and associates. Dr. Adams (Director of Neonatology at
Mount Sinai Medical Center) has been investigating the effects of pGz motion on
numerous biological modalities for over 5 years and his research is funded by a grant
from Miami Heart Institute and is approved by the Mt. Sinai IACUC Committee of which
he is a member. The Principle Investigator’s (PI) measurement of NO in this model is
only one of many studies under current investigation by Dr. Adams and his associates,
Dr.’s Wu and Bassuk. Dr. Adams et al. have several publications regarding pGz and its
effects in the Journals of Applied Physiology, Circulation, and Resuscitation.
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How long will the animals be in fibrillation and/or subject to resuscitation? You are
monitoring every 10 minutes suggesting a rather prolonged period. How long will
the resuscitations last?
The animals will be in fibrillation for up to 40 minutes. First baseline specimens are
drawn; thereafter ventricular fibrillation is induced with the platform set into motion after
a three-minute period. Blood draws are at 10-minute intervals (X3). The animals are
sedated in the holding pen, prior to arrival in the research lab, and held in a surgical plane
of anesthesia throughout the experiments without regaining consciousness. If the animals
survive the experiment (ventricular fibrillation for up to 40 minutes) they are immediately
euthanized with a lethal barbiturate dose (euthasol/ pentobarbital concentration of 5cc IV
push) as per IACUC requirements. This protocol has been used by Dr. Adams in prior
pGz experiments and with IACUC approval.

Curare wipes out muscle tone - does this affect blood pressure or other
physiological variables that would in turn affect NO production?
Curare is not used in any pGz experiments. Neuromuscular blockade is induced with
Pancurium Bromide at 0.1mg/kg with continued supplementation as necessary. The depth
of anesthesia is determined by loss of corneal and spinal reflex with accompanying heart
beat of 150 per minute as is the norm in young pigs. The PI has reviewed several
pharmacology and anesthesia references and has not found any report of Pancurium
Bromide affecting the production of NO. However, side effects of Pancurium Bromide
are listed as hypertension and tachycardia. As NO is a potent vasodilator, the possibility
of these side effects occurring, resulting from NO’s production or inhibition, will be
addressed during the discussion and limitations portion of the thesis document and
defense.

The animals are premedicated with ketamine (10 mg/kg, intramuscularly), in the holding
pen prior to entering the lab, followed by anesthesia with propofol given at 6 mg/kg for
induction TV and 0.5mg/kg/min for maintenance. Possible side effects of these
medications will also be discussed in the final thesis document.
111. G. 3. Special housing.
Yes, the animals undergo special housing as they are housed at the Harry Pearlman
Research Center which is the Animal Research Laboratory at Mt. Sinai Medical Center
and is accredited by the American Association for Accreditation of Laboratory Animal
Care and adheres to all requirements and provisions of the Animal Welfare Act, PHS
policies on Animal Care and Use, and USDA regulations. Three to five pigs are housed at
one time. Staff for feeding, cleaning, and routine veterinary care is provided by the
Research Department at Mt. Sinai. The staff veterinarian is Julia Zarias, D.M.V.
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III. G. 4. Section X (D)
Pain or distress experienced by subjects.

The answer should be “no” as the animals are anesthetized, prior to entering the lab, and
continuously supplemented with anesthesia throughout experimentation (as described in
section 11B) and therefore experience no pain or distress. This information is confirmed
by the Mt. Sinai Research Laboratory Veterinarian Julia Zarias, D.M.V.
X(D). Describe the measures which will be taken to alleviate pain or distress. If no
measures are taken, you must justify this decision.
The measures taken to alleviate pain or distress are fully described in section 11B.
IV. A. The Yorkshire species is Sus Scrofa.
Please describe more fully “other possible complications” which may require the use
of additional animals.
Other possible complications requiring use of additional animals, for the pGz
experiments, include death from ventricular arrhythmia, unknown existing pathology in
the animal, and complications from intubation, vessel cannulation, and anesthesia.
However, as an anesthesiologist (Dr. Bassuk) is present during all experiments and
performs all invasive procedures and anesthesia administration, the animals are closely
monitored.

IV. D. Is the 10 animals “per study” suggested by your analysis the number of
animals total or the number of animals in each of your two groups? If the latter,
then your effective sample size is likely too small (N=12) to detect a significant
difference. Explain.

The study uses 12 animals total, 6 in each experiment and is based on previous pGz
studies, recommendations by Dr. Adams, Utstein guidelines, provisions of Miami Heart
Institute, and as is appropriate for a pilot study for feasibility. Should the study support
trends or significant differences between types of resuscitation (pGz or Standard CPR),
Dr. Adams plans to repeat the study, after conducting a power analysis using the results
of this pilot study, with at least 10 animals in each group.

The section on statistical power made no sense (to me). What statistical tests are
used to detect changes in NO level within subjects and to compare groups? What is
the predicted variance in NO levels across comparison groups? What is the alpha
level?
A repeated measures experimental design will be used for the within group experiments,
differences in NO levels during pGz and standard CPR, and performed using a one-way
analysis of variance (ANOVA) consisting of one independent variable (resuscitation) and
one dependent variable (NO). The advantage of the repeated measures design is that it
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allows for multiple values to be obtained from the same animal using the animal as its
own control and ensuring a high amount of equivalence among the study subjects.
Comparison between groups, greater NO levels during pGz resuscitation versus standard
CPR, will be made using a two- way ANOVA consisting of two independent variables
(pGz and standard CPR) and one dependent variable (NO). The dependent variable
remains continuous as per protocol for ANOVA testing. Frequency distribution of the
data will be determined and an F-ratio obtained. If the F-ratio is deemed significant, the
source of significance will be determined using the appropriate post hoc test to compare
group means and decrease possibility of a type-1 error. Data will be analyzed using an
Instat software program and expressed as means + SD, with statistical significance
(alpha) set at /?<0.05.
As this study represents pilot work, and as NO has never been measured in the pGz
model before, it is not possible to estimate or predict variance in NO levels across
comparison groups.
Vll.B. The methods of standard CPR resuscitation that will be used for one of the
groups are not described.

The method of standard CPR used for comparison in these experiments is via the
Thumper device. The Thumper is a mechanical device for compressing the chest in a
uniform, repetitive fashion with constant rate and force and simulates manual chest
compressions. The Thumper has also been utilized for resuscitation in humans,
specifically by paramedics in the field.
VI1. H. Again, please clarify if the pigs are euthanized at the end of surgery without
gaining consciousness.

At the completion of the experiments, all animals will be euthanized by a lethal
barbiturate (as stated in ll.B.) dose as per IACUC requirements without regaining
consciousness.
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Florida Interxatioxai. University
Miamis public research university

Institutional Animal Care and Use Committee
MEMORANDUM

From:

Ingrid Gunnlaugsson, Principal Investigator
Dr. McDonough
Yvette Peterson, IACUC Coordinator

Date:

January 29, 2003

To:

Re:

Approval of Protocol

The Institutional Animal Care and Use Committee at FIU has approved the

following protocol:

Protocol

Effects of Periodic Acceleration on Nitric Oxide During Resuscitation
in Anesthetized Pigs

Protocol Approval

02-019

Number:
Approval
Date:
Modifications:
None

10/22/02

Renewal
Date:

10/22/03

FIU Animal Welfare Assurance Number:
#A3096-01
Please address questions or concerns about this protocol to:
Yvette Peterson, IACUC Coordinator
Phone: 305-348-2494
Fax: 305-348-4117
Email: irbiacuc@fiu.edu
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